Â© 2000-2024 QIAGEN. All rights reserved.

Ingenuity Canonical Pathways	 -log(p-value)	Ratio	z-score	Molecules	
RHO GTPase cycle	2.59E01	1.73E-01	8.832	ABL2,AKAP13,ARAP2,ARHGAP17,ARHGAP23,ARHGAP26,ARHGAP31,ARHGAP32,ARHGAP35,ARHGAP5,ARHGEF10,ARHGEF11,ARHGEF12,ARHGEF28,ARHGEF3,ARHGEF9,BCR,CDC42BPA,CDC42BPB,CHN2,CLTC,CPD,CPNE8,DOCK1,DOCK4,DOCK6,DOCK9,ERBIN,FAM135A,FARP1,FGD5,FILIP1,FMNL2,FRS2,GIT2,HNRNPC,ITSN2,KALRN,KIDINS220,LEMD3,MCF2L,MSI2,MTR,MYO6,MYO9A,NCKAP1,OPHN1,PDE5A,PEAK1,PHIP,PICALM,PIK3CA,PIK3R1,PIK3R3,PKP4,PLD1,PLEKHG1,PREX2,RALGAPA1,RAPGEF1,RASAL2,RASGRF2,ROCK1,SH3PXD2A,SH3RF1,SLK,SOS2,SPATA13,SPEN,SPTAN1,SPTBN1,SRGAP1,SRGAP2,STARD13,TRIO,UACA,USP9X,WIPF1	
Protein Kinase A Signaling	1.01E01	1.19E-01	2.214	ADCY9,ADD1,AKAP10,AKAP13,ANAPC1,BRAF,CREB3L2,CREBBP,FLNB,GNAQ,GNG12,ITPR1,ITPR2,ITPR3,LEF1,LIPE,MAP3K1,MTMR3,MYH10,NFAT5,PDE5A,PDE7B,PDE8A,PHKB,PLCB1,PLCB4,PLCG1,PPP1R12A,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,PTEN,PTK2,PTPN14,PTPN4,PTPRB,PTPRG,PTPRJ,PTPRK,PTPRM,ROCK1,TCF4,TCF7L1,TCF7L2,TGFB2,TGFBR2	
Chronic Myeloid Leukemia Signaling	9.68E00	1.37E-01	5.191	ABCB1,AKT3,BCL2L1,CDK6,FOXO3,FZD6,GAB2,HDAC4,HDAC7,HDAC8,LEF1,MECOM,MSI2,NFAT5,NOTCH4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,PTEN,RB1,RBL2,RPTOR,SIN3A,SIRT1,SOS2,STAT3,TCF4,TCF7L1,TCF7L2,TGFB2,TGFBR2,XIAP	
Oxytocin Signaling Pathway	9.5E00	1.35E-01	4.768	AKT3,ATP2B4,CACNA1A,CREB3L2,CREBBP,GNAQ,GNG12,ITPR1,ITPR2,ITPR3,LIPE,MAP2K4,MAP2K5,MEF2C,MPRIP,MYH10,MYH9,MYO10,MYO18A,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLA2G4A,PLCB1,PLCB4,PPP1R12A,Ppp1r12b,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,PRKG1,ROCK1,SMARCC2,SOS2	
Senescence Pathway	9.31E00	1.3E-01	4.218	ACVR1,AKT3,ANAPC1,ASXL2,BMPR2,BRAF,CACNA1A,CDK6,CREBBP,ELF2,EP400,ETS1,FOXO3,HIPK2,ITPR2,ITPR3,ITSN2,KAT2B,MAP2K4,MAP2K5,NF1,NFAT5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP2R5E,PPP3CA,PPP3CC,PTEN,RB1,RBL2,RPS6KA5,SIRT1,SMAD5,TGFB2,TGFBR2,TGFBR3	
Epithelial Adherens Junction Signaling	9.21E00	1.71E-01	-0.962	ACVR1,AFDN,AKT3,ARHGAP35,BMPR2,CTNNA1,FER,IGF1R,LEF1,MAGI1,MYH10,NF2,NOTCH4,PPM1L,PPP2R5E,PTEN,RAPGEF1,ROCK1,STK3,TCF4,TCF7L1,TCF7L2,TGFB2,TGFBR2,TGFBR3,TNS1,YAP1	
Cardiac Hypertrophy Signaling (Enhanced)	9.08E00	1.03E-01	6.532	ACVR1,ADCY9,AKAP13,AKT3,ATF6,BMPR2,CACNA1A,Diaph2,DLG1,FZD6,GHR,GNAQ,GNG12,HDAC4,HDAC7,HDAC8,IGF1R,IL17RD,INPP5F,ITGA1,ITPR1,ITPR2,ITPR3,MAP2K4,MAP2K5,MAP3K1,MAP3K2,MAP3K20,MAP3K3,MEF2C,NFAT5,PDE5A,PDE7B,PDE8A,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,PRKG1,PTEN,PTK2,ROCK1,RPS6KA5,STAT3,TGFB2,TGFBR2,TGFBR3	
Factors Promoting Cardiogenesis in Vertebrates	8.84E00	1.7E-01	4.379	ACVR1,APC,BMPR2,CREB3L2,CREBBP,FZD6,LEF1,LRP5,LRP6,MAP2K4,MEF2C,PLCB1,PLCB4,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,ROCK1,SMAD5,TCF4,TCF7L1,TCF7L2,TGFB2,TGFBR2,TGFBR3	
Role of NFAT in Cardiac Hypertrophy	8.74E00	1.43E-01	4.811	ADCY9,AKT3,CACNA1A,GNAQ,GNG12,HDAC4,HDAC7,HDAC8,IGF1R,ITPR1,ITPR2,ITPR3,MAP2K4,MAP3K1,MEF2C,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,RCAN2,SOS2,TGFB2,TGFBR2	
WNK Renal Signaling Pathway	8.5E00	1.98E-01	3.000	AKT3,ANAPC1,CBL,INSR,KLHL3,LRRC8C,NR3C2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCE,PRKCH,PRKCI,PRKD3,PRKN,RPS6KA5,SLC12A6,UBR1,WNK1,XIAP	
Gap Junction Signaling	8.27E00	1.2E-01	1.441	ADCY9,AKT3,CREB3L2,CREBBP,CSNK1G1,DLG1,GNAQ,ITPR1,ITPR2,ITPR3,LEF1,LRP5,LRP6,MAP2K4,MAP2K5,MAP3K2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLA2G4A,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,PRKG1,PTPRM,SMAD5,SMARCC2,SOS2,TCF4,TCF7L1,TCF7L2,TJP1	
HGF Signaling	8.11E00	1.74E-01	4.472	AKT3,DOCK1,ELF2,ETS1,GAB1,ITGA1,MAP2K4,MAP3K1,MAP3K2,MAP3K3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,PTK2,RAPGEF1,SOS2,STAT3	
Hepatic Fibrosis Signaling Pathway	7.79E00	1.06E-01	5.191	ACVR1,AKT3,APC,BMPR2,BRAF,CACNA1A,CREB3L2,CREBBP,CSNK1G1,FLT1,FLT4,FOXO1,FZD6,IRAK3,ITGA1,LEF1,LRP5,LRP6,MAP2K4,MAP2K5,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,PTEN,PTK2,ROCK1,SOS2,STAT3,TCF4,TCF7L1,TCF7L2,TGFB2,TGFBR2,TGFBR3,TRPM7,VEGFC,VEGFD,YAP1	
Role of Tissue Factor in Cancer	7.79E00	1.4E-01	4.271	ACVR1,AKT3,BCL2L1,BMPR2,BRAF,FLT1,FLT4,GNAQ,MAP2K4,MAP2K5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,Ppp2r5c,PPP2R5E,PTEN,PTK2,RB1,RBL2,RPS6KA3,RPS6KA5,TGFB2,TGFBR2,TGFBR3,VEGFC,YES1,ZEB1	
Myelination Signaling Pathway	7.69E00	1.16E-01	3.893	ACVR1,AKT3,APC,ARHGAP35,ARHGAP5,BMPR2,BRAF,CREB3L2,CREBBP,FZD6,HDAC4,HDAC7,HDAC8,IGF1R,LAMA3,LAMA4,LAMB2,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPP3CA,PPP3CC,PTEN,PTK2,RAPGEF2,ROCK1,RPTOR,SLC16A1,SMAD5,SMARCA4,SOS2,TCF4,TCF7L2,YES1,ZEB2	
Pancreatic Secretion Signaling Pathway	7.69E00	1.3E-01	5.303	ADCY9,AKT3,ARHGEF10,ARHGEF11,ARHGEF12,ARHGEF3,ARHGEF9,ATP2B4,GNAQ,ITPR1,ITPR2,ITPR3,LIPE,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP1R12A,PRKCE,PRKCH,PRKCI,PRKD3,ROCK1,RPTOR,STIM1,STXBP5,STXBP6,VTI1A,WNK1	
PTEN Signaling	7.62E00	1.59E-01	-3.578	AKT3,BCL2L1,BMPR2,CBL,FLT1,FLT4,FOXO1,FOXO3,GHR,IGF1R,INPP5F,INSR,ITGA1,MAGI1,MAGI3,PIK3CA,PIK3R1,PIK3R3,PREX2,PTEN,PTK2,SOS2,TGFBR2,TGFBR3	
Signaling by VEGF	7.6E00	1.85E-01	4.123	AKT3,CTNNA1,DOCK1,ELMO1,FLT1,FLT4,ITPR1,ITPR2,ITPR3,MAPKAP1,NCKAP1,NRP1,PIK3CA,PIK3R1,PLCG1,PTK2,RICTOR,ROCK1,VEGFC,VEGFD	
DNA Methylation and Transcriptional Repression Signaling	7.59E00	1.94E-01	2.673	ARID4B,CDK12,CDK13,CDK14,CDK19,CDK6,CHD4,DNMT3A,RB1,RBL2,SAP130,SIN3A,TCF12,TCF20,TCF23,TCF4,TET2,TET3,ZEB1	
Beta-catenin independent WNT signaling	7.3E00	1.86E-01	2.000	AGO1,AGO3,CLTC,FZD6,GNG12,ITPR1,ITPR2,ITPR3,LEF1,NLK,PLCB1,PPP3CA,PRKG1,SMURF1,SMURF2,TCF7L1,TCF7L2,TNRC6B,TNRC6C	
Glioma Signaling	7.18E00	1.68E-01	3.207	AKT3,CDK6,HDAC4,HDAC7,HDAC8,IGF1R,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,PTEN,RB1,RBL2,SIN3A,SOS2	
VEGF Family Ligand-Receptor Interactions	7.15E00	2.02E-01	4.000	AKT3,FLT1,FLT4,NRP1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLA2G4A,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,SOS2,VEGFC,VEGFD	
Non-Small Cell Lung Cancer Signaling	7.14E00	1.91E-01	2.714	AKT3,CDK6,FOXO3,HDAC4,HDAC7,HDAC8,ITPR1,ITPR2,ITPR3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,RB1,RBL2,SIN3A,SOS2	
Thrombin Signaling	6.98E00	1.29E-01	4.379	ADCY9,AKT3,ARHGEF10,ARHGEF11,ARHGEF12,ARHGEF28,ARHGEF3,ARHGEF9,GNAQ,GNG12,ITPR1,ITPR2,ITPR3,MPRIP,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP1R12A,Ppp1r12b,PRKCE,PRKCH,PRKCI,PRKD3,PTK2,ROCK1	
ID1 Signaling Pathway	6.91E00	1.34E-01	3.272	ACVR1,AKT3,APP,ATF6,BCL2L1,BMPR2,BRAF,CREBBP,ETS1,FN1,FOXO3,IGF1R,LIFR,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTEN,SMAD5,STAT3,TGFB2,TGFBR2,TGFBR3,VEGFC,VEGFD,YES1,ZNF148	
AMPK Signaling	6.82E00	1.24E-01	1.807	ACACA,ACACB,AKT3,ARID1A,ARID2,CPT1A,CREB3L2,CREBBP,FOXO1,FOXO3,GNAQ,GNG12,INSR,KAT2B,LIPE,PBRM1,PHLPP1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1H,PPM1L,PPP2R5E,RPTOR,SIRT1,SMARCA2,SMARCA4,SMARCC2,STIM1	
Sperm Motility	6.76E00	1.21E-01	3.606	ABL2,DSTYK,DYRK1A,EPHA3,EPHA4,FER,FLT1,FLT4,GNAQ,GNG12,IGF1R,INSR,ITPR1,ITPR2,ITPR3,MAP2K4,MAP2K5,MERTK,PEAK1,PLA2G4A,PLCB1,PLCB4,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,PRKG1,PTK2,TEK,YES1	
CLEAR Signaling Pathway	6.73E00	1.16E-01	0.180	AKT3,ATP6V0A1,BMPR2,CREB3L2,CREBBP,DEPDC5,FLT1,FLT4,FNIP1,GHR,IGF1R,INSR,ITPR1,ITPR2,ITPR3,MAP4K3,MID1,PLCG1,PPM1L,PPP2R5E,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,PRKN,RPTOR,TGFB2,TGFBR2,TGFBR3,UVRAG,WDR59	
Regulation of the Epithelial-Mesenchymal Transition Pathway	6.62E00	1.33E-01	NaN	AKT3,APC,BRAF,ETS1,FRS2,FZD6,GAB1,LEF1,MAP2K4,MAP2K5,NOTCH4,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SMURF1,SOS2,STAT3,TCF4,TCF7L1,TCF7L2,TGFB2,TGFBR2,ZEB1,ZEB2	
Ribonucleotide Reductase Signaling Pathway	6.58E00	1.4E-01	3.674	AKT3,ARID1A,ARID2,BRAF,BTRC,CDK6,CREB3L2,CREBBP,FOXO3,MAP2K4,PARP14,PBRM1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RB1,RPTOR,SETD2,SMARCA2,SMARCA4,SMARCC2,STAT3,TNKS	
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis	6.53E00	1.08E-01	NaN	AKT3,APC,CREB3L2,CREBBP,CSNK1G1,FN1,FZD6,GNAQ,IRAK3,LEF1,LRP5,LRP6,MAP2K4,NFAT5,NLK,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,ROCK1,STAT3,TCF4,TCF7L1,TCF7L2,VEGFC,VEGFD	
Docosahexaenoic Acid (DHA) Signaling	6.51E00	1.2E-01	5.112	ADCY9,AKT3,APP,BCL2L1,BRAF,CREB3L2,CREBBP,FOXO1,GNAQ,ITPR1,ITPR2,ITPR3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLA2G4A,PLCB1,PLCB4,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,RPTOR,SPTBN1,STXBP5,STXBP6,SYT7,TGFB2	
Netrin Signaling	6.48E00	1.39E-01	4.491	ABLIM1,AKT3,CACNA1A,DOCK1,ENAH,ITPR1,ITPR2,ITPR3,NFAT5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,PRKG1,PTK2,TRIO,VTI1A	
Mouse Embryonic Stem Cell Pluripotency	6.45E00	1.73E-01	3.771	AKT3,APC,BMPR2,CREBBP,FZD6,LEF1,LIFR,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SMAD5,SOS2,STAT3,TCF4,TCF7L1,TCF7L2,XIAP	
Circadian Rhythm Signaling	6.35E00	1.16E-01	NaN	ADCY9,BRAF,BTRC,CACNA1A,CREB3L2,CREBBP,DBP,GNAQ,GNG12,HLF,ITPR1,ITPR2,ITPR3,MAP2K4,MAP2K5,NR1D1,NR1D2,PLCB1,PLCB4,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,PRKG1,RORA,RPS6KA5,RPTOR,SIRT1,SMARCC2,YES1	
EGF Signaling	6.34E00	2.32E-01	3.606	AKT3,ITPR1,ITPR2,ITPR3,MAP2K4,MAP3K1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,SOS2,STAT3	
MSP-RON Signaling in Cancer Cells Pathway	6.32E00	1.5E-01	4.359	AKT3,ARNT,BRAF,CREB3L2,CREBBP,ELF2,ETS1,LEF1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,RPS6KA3,SOS2,STAT3,TCF4,TCF7L1,TCF7L2,VEGFC,VEGFD	
Pulmonary Fibrosis Idiopathic Signaling Pathway	6.3E00	1.07E-01	4.564	ACVR1,AKT3,BMPR2,BRAF,CREBBP,EFNB2,FN1,FOXO1,FOXO3,FZD6,JARID2,LEF1,MAP2K4,NOTCH4,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKN,PTEN,PTK2,ROCK1,RPS6KA3,RPS6KA5,SOS2,STAT3,TCF4,TCF7L1,TCF7L2,TGFB2,TGFBR2,TGFBR3,WWTR1,YAP1	
Nitric Oxide Signaling in the Cardiovascular System	6.15E00	1.58E-01	3.900	AKT3,CACNA1A,FLT1,FLT4,ITPR1,ITPR2,ITPR3,PDE5A,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCE,PRKCH,PRKCI,PRKD3,PRKG1,VEGFC,VEGFD	
CXCR4 Signaling	6.13E00	1.37E-01	4.025	ADCY9,AKT3,ARHGEF11,DOCK1,ELMO1,GNAQ,GNG12,ITPR1,ITPR2,ITPR3,MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PRKCE,PRKCH,PRKCI,PRKD3,PTK2,ROCK1	
Renin-Angiotensin Signaling	6.09E00	1.57E-01	4.123	ADCY9,GNAQ,ITPR1,ITPR2,ITPR3,MAP2K4,MAP3K1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,PTK2,SOS2,STAT3	
Serotonin Receptor Signaling	6.09E00	9.38E-02	5.126	ADCY9,AKT3,APP,ARFGEF1,BRAF,CACNA1A,CREB3L2,CREBBP,FOXO1,FOXO3,GNAQ,GNG12,KALRN,LIPE,MAOA,MAP2K4,MAP2K5,MPRIP,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLA2G4A,PLCB1,PLCB4,PLCG1,PLD1,PPP1R12A,Ppp1r12b,PRKCE,PRKCH,PRKCI,PRKD3,RB1,RBL2,ROCK1,RPS6KA3,SHANK3,STAT3,STIM1,TGFB2,VWF,YAP1,YES1	
VEGF Signaling	6.07E00	1.72E-01	3.742	AKT3,ARNT,BCL2L1,FLT1,FLT4,FOXO1,FOXO3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PTK2,ROCK1,SOS2,VEGFC,VEGFD	
CCR3 Signaling in Eosinophils	6.01E00	1.49E-01	3.317	GNAQ,GNG12,ITPR1,ITPR2,ITPR3,MPRIP,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLA2G4A,PLCB1,PLCB4,PPP1R12A,Ppp1r12b,PRKCE,PRKCH,PRKCI,PRKD3,ROCK1	
IL-3 Signaling	6.01E00	1.9E-01	3.357	AKT3,FOXO1,GAB2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,RAPGEF1,STAT3	
Glioblastoma Multiforme Signaling	6E00	1.35E-01	2.683	AKT3,APC,CDK6,FOXO1,FZD6,IGF1R,ITPR1,ITPR2,ITPR3,LEF1,NF1,NF2,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PTEN,RB1,SOS2	
Orexin Signaling Pathway	5.95E00	1.18E-01	4.914	ADCY9,AKT3,ATP6V0A1,CACNA1A,FOXO1,GNAQ,GNG12,ITPR1,ITPR2,ITPR3,PI4KA,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PIKFYVE,PIP4K2A,PLA2G4A,PLCB1,PLCB4,PLCG1,PLD1,PRKCE,PRKCH,PRKCI,PRKD3,RPTOR,SMAD5	
Integrin Signaling	5.91E00	1.23E-01	3.838	AKT3,ARHGAP26,ARHGAP5,ASAP1,BRAF,DOCK1,ITGA1,MAP2K4,MPRIP,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PIKFYVE,PLCG1,PPP1R12A,Ppp1r12b,PTEN,PTK2,RAPGEF1,ROCK1,SOS2,TLN1,TLN2,TSPAN5,WIPF1	
Growth Hormone Signaling	5.85E00	1.97E-01	3.606	GHR,IGF1R,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,RPS6KA3,RPS6KA5,STAT3	
ILK Signaling	5.82E00	1.24E-01	3.130	AKT3,CREB3L2,CREBBP,DOCK1,FLNB,FN1,LEF1,MAP2K4,MYH10,MYH9,MYO10,MYO18A,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP1R12A,PPP2R5E,PTEN,PTK2,RICTOR,RPS6KA5,VEGFC,VEGFD	
Pancreatic Adenocarcinoma Signaling	5.81E00	1.51E-01	3.464	AKT3,BCL2L1,HDAC4,HDAC7,HDAC8,MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLD1,RB1,RBL2,SIN3A,STAT3,TGFB2,TGFBR2,VEGFC,VEGFD	
Reelin Signaling in Neurons	5.81E00	1.45E-01	4.243	AFDN,AKT3,APP,ARHGEF10,ARHGEF11,ARHGEF12,ARHGEF28,ARHGEF3,ARHGEF9,DNAH3,LRP8,MAP2K4,MAP2K5,MAPK8IP3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RAPGEF1,YES1	
Huntington's Disease Signaling	5.81E00	1.09E-01	2.683	AKT3,BCL2L1,CLTC,CREB3L2,CREBBP,DNAJC5,DNM3,GNAQ,GNG12,HDAC4,HDAC7,HDAC8,HIP1,IGF1R,ITPR1,MAP2K4,NCOR1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PRKCE,PRKCH,PRKCI,PRKD3,PSME4,SIN3A,SOS2,VTI1A	
ERK/MAPK Signaling	5.79E00	1.21E-01	3.545	BRAF,CREB3L2,CREBBP,DOCK1,ELF2,ETS1,ITGA1,KSR1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLA2G4A,PLCG1,PPM1L,PPP1R12A,PPP2R5E,PRKCE,PRKCI,PTK2,RAPGEF1,RPS6KA5,SOS2,STAT3,TLN1,TLN2	
Adipogenesis pathway	5.76E00	1.44E-01	-0.894	ACVR1,BMPR2,EBF1,FBXW7,FOXO1,FZD6,HDAC4,HDAC7,HDAC8,KAT2B,KAT6A,Kat6b,NR1D1,RB1,RUNX1T1,SAP130,SENP2,SIN3A,SIRT1,SMAD5	
FcÎ³ Receptor-mediated Phagocytosis in Macrophages and Monocytes	5.7E00	1.7E-01	3.500	AKT3,CBL,DOCK1,GAB2,PIK3R1,PIK3R3,PLCG1,PLD1,PRKCE,PRKCH,PRKCI,PRKD3,PTEN,TLN1,TLN2,YES1	
Regulation of lipid metabolism by PPARalpha	5.56E00	1.51E-01	3.051	ARNT,CDK19,CHD9,CPT1A,CREBBP,HMGCS2,MED13,MED13L,MED27,NCOA1,NCOA2,NCOR1,NR1D1,NRF1,RORA,SIN3A,TBL1X,THRAP3	
FGF Signaling	5.52E00	1.74E-01	3.742	AKT3,CREB3L2,CREBBP,FRS2,GAB1,ITPR1,MAP3K1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,RPS6KA5,SOS2,STAT3	
NGF Signaling	5.51E00	1.5E-01	4.000	AKT3,CREB3L2,CREBBP,GAB1,MAP2K4,MAP3K1,MAP3K2,MAP3K3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,ROCK1,RPS6KA3,RPS6KA5,SOS2,TRIO	
Opioid Signaling Pathway	5.47E00	1.07E-01	3.545	ADCY9,AKT3,BRAF,CACNA1A,CLTC,CREB3L2,CREBBP,GNAQ,GNG12,GRK5,ITPR1,ITPR2,ITPR3,LEF1,MAP2K4,MAP2K5,PLCB1,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,RPS6KA3,RPS6KA5,SOS2,TCF4,TCF7L1,TCF7L2,YES1	
Eicosanoid Signaling	5.47E00	1.07E-01	5.292	ABCC4,ADCY9,AKT3,AP1G1,BRAF,CREB3L2,CREBBP,ETS1,GNAQ,GNG12,LEF1,MAPKAP1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLA2G4A,PLCB1,PLCB4,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,RPS6KA3,TCF4,TCF7L1,TCF7L2,VEGFC,VEGFD	
Ovarian Cancer Signaling	5.45E00	1.33E-01	2.333	AKT3,APC,BRAF,FZD6,HDAC4,HDAC7,HDAC8,LEF1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTEN,RB1,RBL2,SIN3A,TCF4,TCF7L1,TCF7L2,VEGFC,VEGFD	
Aldosterone Signaling in Epithelial Cells	5.4E00	1.28E-01	4.359	DNAJC1,DNAJC13,DNAJC5,ITPR1,ITPR2,ITPR3,NR3C2,PI4KA,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PIKFYVE,PIP4K2A,PLCB1,PLCB4,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,SOS2	
Endocannabinoid Cancer Inhibition Pathway	5.38E00	1.36E-01	-2.982	ADCY9,AKT3,CREB3L2,CREBBP,GNAQ,LEF1,MAP2K4,MAP2K5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,ROCK1,RPTOR,TCF4,TCF7L1,TCF7L2,VEGFC,VEGFD	
IL-15 Production	5.35E00	1.46E-01	4.243	ABL2,DSTYK,DYRK1A,EPHA3,EPHA4,FER,FLT1,FLT4,IGF1R,INSR,MAP2K4,MAP2K5,MERTK,PEAK1,PRKCI,PTK2,TEK,YES1	
Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis	5.32E00	1.14E-01	NaN	ACVR1,AKT3,APC,BMPR2,CBL,CSNK1G1,FOXO1,FZD6,LEF1,LRP5,LRP6,MAP2K4,NFAT5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,PPP3CC,SMAD5,SMURF1,TAB2,TCF4,TCF7L1,TCF7L2,XIAP	
WNT/Î²-catenin Signaling	5.32E00	1.26E-01	0.894	ACVR1,AKT3,APC,APPL2,BMPR2,BTRC,CREBBP,CSNK1G1,FZD6,GNAQ,LEF1,LRP5,LRP6,NLK,PPM1L,PPP2R5E,TCF4,TCF7L1,TCF7L2,TGFB2,TGFBR2,TGFBR3	
Synaptogenesis Signaling Pathway	5.3E00	1.02E-01	4.747	ADCY9,AFDN,AKT3,BRAF,CADM1,CDH13,CLASP2,CREB3L2,CREBBP,DNAJC5,EFNB2,EPHA3,EPHA4,FARP1,ITPR1,ITSN2,KALRN,LRP8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCE,RAPGEF1,SOS2,STXBP5,STXBP6,SYT7,TLN1,VTI1A,YES1	
Human Embryonic Stem Cell Pluripotency	5.3E00	1.19E-01	4.491	ACVR1,AKT3,APC,BMPR2,BRAF,FOXO1,FZD6,LIFR,MAP2K4,MAP2K5,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCE,PRKCH,PRKCI,PRKD3,SMAD5,SOS2,STAT3,TGFB2,TGFBR2	
RORA activates gene expression	5.29E00	3.89E-01	2.646	CHD9,CPT1A,CREBBP,NCOA1,NCOA2,RORA,TBL1X	
Sertoli Cell-Sertoli Cell Junction Signaling	5.28E00	1.11E-01	4.041	AFDN,AKT3,CDH13,CREB3L2,CREBBP,CTNNA1,DLG1,EPB41,IGSF5,LAMA3,LAMA4,LAMB2,MAP2K4,MAP3K1,MAP3K2,MAP3K20,MAP3K3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,SORBS1,SPTAN1,SPTBN1,TGFBR2,TJP1	
Actin Cytoskeleton Signaling	5.25E00	1.11E-01	2.558	APC,ARHGAP35,ARHGEF12,DOCK1,FN1,GNG12,ITGA1,MPRIP,MYH10,MYH9,MYO10,MYO18A,NCKAP1,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP1R12A,Ppp1r12b,PTK2,ROCK1,SOS2,SSH2,TLN1,TLN2,TRIO	
Estrogen Receptor Signaling	5.25E00	9.29E-02	4.333	ADCY9,AKT3,CACNA1A,CREB3L2,CREBBP,FOXO1,FOXO3,GNAQ,GNG12,IGF1R,MED13,MED13L,MED27,MPRIP,NCOA1,NCOA2,NCOR1,NRF1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP1R12A,Ppp1r12b,PRKCE,PRKCH,PRKCI,PRKD3,PTEN,RBFOX2,ROCK1,SOS2,THRAP3,VEGFC,VEGFD	
Semaphorin Neuronal Repulsive Signaling Pathway	5.24E00	1.33E-01	-0.447	AKT3,ARHGEF12,FARP1,ITGA1,MAP2K4,MAP2K5,MPRIP,NRP1,Pde4d,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PLXNA2,PPP1R12A,Ppp1r12b,PRKG1,ROCK1,SEMA6A	
Autophagy	5.22E00	1.15E-01	1.225	AKT3,AMBRA1,ARNT,BIRC6,CREB3L2,CREBBP,FOXO1,FOXO3,INSR,MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP2R5E,PPP3CA,PPP3CC,PTEN,RB1CC1,RPTOR,SESN1,SIRT1,TGFB2,UVRAG	
Prostate Cancer Signaling	5.2E00	1.49E-01	NaN	AKT3,CREB3L2,CREBBP,FOXO1,HDAC4,HDAC7,HDAC8,LEF1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTEN,RB1,RBL2,SIN3A,SOS2	
Insulin Secretion Signaling Pathway	5.18E00	1.05E-01	5.292	ADCY9,AGO1,AGO3,CACNA1A,CREB3L2,CREBBP,EIF4G1,EIF4G3,GHR,GNAQ,INSR,ITPR1,ITPR2,ITPR3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,RPS6KA5,STAT3,VTI1A,YES1	
Signaling by NTRK1 (TRKA)	5.14E00	1.73E-01	3.742	BRAF,CLTC,DNM3,FRS2,KIDINS220,MAP2K5,MEF2C,PIK3CA,PIK3R1,PLCG1,RAPGEF1,RPS6KA3,RPS6KA5,STAT3	
Axonal Guidance Signaling	5.14E00	8.63E-02	NaN	ABLIM1,ADAMTS9,AKT3,ARHGEF11,ARHGEF12,DOCK1,EFNB2,EPHA3,EPHA4,FZD6,GNAQ,GNG12,HERC2,ITGA1,KALRN,LNPEP,NFAT5,NRP1,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PLXNA2,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,PTK2,ROCK1,SEMA3C,SEMA6A,SEMA7A,SOS2,SRGAP1,SRGAP2,VEGFC,VEGFD,WIPF1	
Regulation of the Epithelial Mesenchymal Transition by Growth Factors Pathway	5.13E00	1.2E-01	4.796	AKT3,BRAF,ETS1,FOXO1,FRS2,GAB1,MAP2K4,MAP2K5,MAP3K1,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SMURF1,SOS2,STAT3,TGFB2,TGFBR2,WWTR1,YAP1,ZEB1,ZEB2	
Apelin Endothelial Signaling Pathway	5.08E00	1.35E-01	3.153	ADCY9,AKT3,ARNT,GNAQ,GNG12,HDAC4,MAP2K4,MEF2C,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PRKCE,PRKCH,PRKCI,PRKD3,TEK	
Superpathway of Inositol Phosphate Compounds	5.05E00	1.1E-01	4.690	INPP5F,IP6K1,ITPKB,PI4KA,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PIKFYVE,PIP4K2A,PLCB1,PLCB4,PLCG1,PPM1H,PPM1L,PPP1R12A,PPP1R16B,PPP2R5E,PPP3CA,PPP3CC,PTEN,PTPRJ,PTPRM,RNGTT,SGPP2,SSH2	
UVB-Induced MAPK Signaling	5.03E00	2.12E-01	3.317	MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCE,PRKCH,PRKCI,PRKD3,RPS6KA3,RPS6KA5	
HIF1Î± Signaling	5.01E00	1.15E-01	4.899	AKT3,ARNT,BRAF,CREBBP,FLT1,FLT4,MAP2K4,MAP2K5,NCOA1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,STAT3,TGFB2,VEGFC,VEGFD	
eNOS Signaling	4.98E00	1.28E-01	4.123	ADCY9,AKT3,FLT1,FLT4,GNAQ,ITPR1,ITPR2,ITPR3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,PRKG1,VEGFC,VEGFD	
IL-8 Signaling	4.97E00	1.14E-01	4.690	AKT3,BCL2L1,BRAF,FLT1,FLT4,GNAQ,GNG12,IRAK3,MAP2K4,MAP4K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLD1,PRKCE,PRKCH,PRKCI,PRKD3,PTK2,ROCK1,TEK,VEGFC,VEGFD	
fMLP Signaling in Neutrophils	4.96E00	1.37E-01	4.000	GNAQ,GNG12,ITPR1,ITPR2,ITPR3,NFAT5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3	
Cholecystokinin/Gastrin-mediated Signaling	4.95E00	1.43E-01	4.123	EPHA4,GNAQ,ITPR1,ITPR2,ITPR3,MAP2K4,MAP2K5,MEF2C,PLCB1,PLCB4,PRKCE,PRKCH,PRKCI,PRKD3,PTK2,ROCK1,SOS2	
GÎ±q Signaling	4.95E00	1.24E-01	4.472	AKT3,GNAQ,GNG12,ITPR1,ITPR2,ITPR3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PLD1,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,ROCK1	
Class I MHC mediated antigen processing and presentation	4.92E00	9.33E-02	5.916	ANAPC1,BTRC,CBLB,FBXL20,FBXL7,FBXO11,FBXW7,HECTD1,HERC1,HERC2,HERC3,HERC4,HLA-A,HUWE1,KLHL2,KLHL3,LMO7,LNPEP,NEDD4L,PRKN,PSME4,RNF144B,RNF213,RNF217,SEC24B,SH3RF1,SMURF1,SMURF2,TRIP12,UBE3A,UBE3C,UBR1,UBR4,WWP1,ZNRF2	
Small Cell Lung Cancer Signaling	4.91E00	1.56E-01	2.333	AKT3,BCL2L1,CDK6,HDAC4,HDAC7,HDAC8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTEN,PTK2,RB1,RBL2,SIN3A	
ERK5 Signaling	4.9E00	1.76E-01	2.887	CREB3L2,CREBBP,ELK4,FOXO3,GAB1,GNAQ,MAP2K5,MAP3K2,MAP3K3,MEF2C,RPS6KA3,RPS6KA5,WNK1	
Semaphorin interactions	4.87E00	1.88E-01	3.464	ARHGAP35,ARHGEF11,ARHGEF12,ITGA1,MYH10,MYH9,NRP1,PLXNA2,ROCK1,SEMA6A,SEMA7A,TLN1	
Dopamine-DARPP32 Feedback in cAMP Signaling	4.85E00	1.18E-01	4.025	ADCY9,CACNA1A,CREB3L2,CREBBP,CSNK1G1,GNAQ,ITPR1,ITPR2,ITPR3,PLCB1,PLCB4,PLCG1,PPM1L,PPP1R12A,PPP2R5E,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,PRKG1	
HEY1 Signaling Pathway	4.78E00	1.24E-01	4.025	ACVR1,AKT3,ARNT,BMPR2,GAB1,MEF2C,NCOR1,NOTCH4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SIN3A,SIRT1,SMAD5,TGFB2,TGFBR2,TGFBR3,VEGFC,VEGFD	
RHOA Signaling	4.71E00	1.37E-01	1.500	ABL2,ARHGAP35,ARHGAP5,ARHGEF11,ARHGEF12,IGF1R,MPRIP,PI4KA,PIKFYVE,PIP4K2A,PLD1,PPP1R12A,Ppp1r12b,PTK2,RAPGEF2,RAPGEF6,ROCK1	
RAC Signaling	4.69E00	1.31E-01	3.873	ELK4,ITGA1,MAP2K4,MAP3K1,MCF2L,NCKAP1,PARD3,PI4KA,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PIKFYVE,PIP4K2A,PLD1,PRKCI,PTK2,SH3RF1	
Mitotic Telophase/Cytokinesis	4.69E00	4E-01	2.449	NIPBL,PDS5A,PDS5B,RAD21,SMC1A,STAG1	
Heme signaling	4.65E00	2.13E-01	-1.667	CHD9,CREBBP,MEF2C,NCOA1,NCOA2,NCOR1,NR1D1,RORA,SIRT1,TBL1X	
Signaling by MET	4.58E00	1.65E-01	3.606	CBL,FN1,GAB1,LAMA3,LAMA4,LAMB2,PIK3CA,PIK3R1,PTK2,PTPRJ,RANBP9,RAPGEF1,STAT3	
Thyroid Cancer Signaling	4.58E00	1.65E-01	2.496	AKT3,BRAF,FOXO1,INSR,LEF1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTEN,TCF4,TCF7L1,TCF7L2	
14-3-3-mediated Signaling	4.57E00	1.34E-01	3.742	AKT3,CBL,FOXO1,MAP2K4,PDCD6IP,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,YAP1	
Insulin Receptor Signaling	4.56E00	1.29E-01	1.886	AKT3,CBL,FOXO1,FOXO3,GAB1,INPP5F,INSR,LIPE,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP1R12A,PRKCI,PTEN,RAPGEF1,RPTOR,SOS2	
PPARÎ±/RXRÎ± Activation	4.56E00	1.13E-01	-2.668	ACVR1,ADCY9,ADIPOR2,BMPR2,CKAP5,CREBBP,GHR,GNAQ,GPD2,INSR,MAP2K4,MAP4K4,MEF2C,NCOR1,NR2C2,PLCB1,PLCB4,PLCG1,SOS2,TGFB2,TGFBR2,TGFBR3	
Acute Myeloid Leukemia Signaling	4.55E00	1.54E-01	3.742	AKT3,BRAF,LEF1,MAP2K4,MAP2K5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SOS2,STAT3,TCF4,TCF7L1,TCF7L2	
RANK Signaling in Osteoclasts	4.55E00	1.54E-01	3.742	AKT3,CBL,MAP2K4,MAP3K1,MAP3K2,MAP3K3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,PPP3CC,TAB2,XIAP	
G alpha (12/13) signalling events	4.52E00	1.63E-01	3.606	AKAP13,ARHGEF10,ARHGEF11,ARHGEF12,ARHGEF3,ARHGEF9,GNG12,KALRN,MCF2L,RASGRF2,ROCK1,SOS2,TRIO	
Circadian Clock	4.49E00	1.86E-01	2.111	BTRC,CHD9,CREBBP,MEF2C,NCOA1,NCOA2,NCOR1,NR1D1,RORA,SIRT1,TBL1X	
Hereditary Breast Cancer Signaling	4.48E00	1.27E-01	NaN	AKT3,ARID1A,ARID2,CDK6,CREBBP,HDAC4,HDAC7,HDAC8,PBRM1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTEN,RB1,SMARCA2,SMARCA4,SMARCC2	
HER-2 Signaling in Breast Cancer	4.41E00	1.06E-01	2.858	AKT3,BRAF,ELF2,ETS1,FOXO1,FOXO3,PARD3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,PTEN,RB1,RBL2,RPTOR,SOS2,STAT3,XIAP,YES1	
FLT3 Signaling in Hematopoietic Progenitor Cells	4.41E00	1.59E-01	3.464	AKT3,CBL,CREB3L2,CREBBP,GAB2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RPS6KA3,RPS6KA5,SOS2,STAT3	
Pulmonary Healing Signaling Pathway	4.39E00	1.11E-01	4.264	BMPR2,BRAF,FZD6,LEF1,MAP2K4,NOTCH4,PRKCE,PRKCH,PRKCI,PRKD3,SMAD5,SOS2,STAT3,TCF4,TCF7L1,TCF7L2,TGFB2,VEGFC,VEGFD,WWTR1,YAP1,YES1	
Adrenomedullin signaling pathway	4.39E00	1.11E-01	4.583	ADCY9,AKT3,ARNT,BRAF,CALCRL,GNAQ,ITPR1,ITPR2,ITPR3,MAP2K4,MAP2K5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKG1,PTK2,SMARCC2,SOS2	
Melatonin Signaling	4.33E00	1.67E-01	3.317	BRAF,GNAQ,MAP2K4,MAP2K5,PLCB1,PLCB4,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,RORA	
P2Y Purigenic Receptor Signaling Pathway	4.31E00	1.28E-01	3.873	ADCY9,AKT3,CREB3L2,CREBBP,GNAQ,GNG12,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3	
Transcriptional regulation of white adipocyte differentiation	4.29E00	1.55E-01	3.606	CDK19,CHD9,CREBBP,EBF1,MED13,MED13L,MED27,NCOA1,NCOA2,NCOR1,TBL1X,THRAP3,ZNF638	
Molecular Mechanisms of Cancer	4.25E00	7.13E-02	6.713	ACVR1,ADCY9,ADGRF5,AKT3,APC,ARHGEF10,ARHGEF11,ARHGEF12,ARHGEF3,ARHGEF9,BCL2L1,BMPR2,BRAF,CALCRL,CBL,CDK6,CREBBP,CTNNA1,FOXO1,FZD6,GAB1,GAB2,GHR,GNAQ,GNG12,HDAC4,HDAC7,HDAC8,HIPK2,IL17RD,ITGA1,LEF1,LRP5,LRP6,MAP2K4,NF1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PRKCE,PRKCH,PRKCI,PRKD3,PTK2,RAPGEF1,RASGRF2,RB1,RBL2,SIN3A,SMAD5,SOS2,TAB2,TCF4,TCF7L1,TCF7L2,TGFB2,TGFBR2,XIAP	
Glutaminergic Receptor Signaling Pathway (Enhanced)	4.22E00	9.23E-02	5.477	ADCY9,AKT3,CACNA1A,CREB3L2,CREBBP,DGKE,DGKH,GNAQ,ITPR1,ITPR2,ITPR3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLA2G4A,PLCB1,PLCB4,PLCG1,PLD1,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,RPTOR,SHANK3,TGFB2,VTI1A	
Transcriptional Regulation by MECP2	4.21E00	1.75E-01	-1.000	AGO1,AGO3,HIPK2,MEF2C,NCOR1,PTEN,PTPN4,SIN3A,TBL1X,TNRC6B,TNRC6C	
Thrombopoietin Signaling	4.21E00	1.75E-01	3.317	GAB2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,STAT3	
WNT/SHH Axonal Guidance Signaling Pathway	4.2E00	1.21E-01	1.886	ADCY9,FZD6,ITPR1,ITPR2,ITPR3,LEF1,MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLXNA2,PRKCI,SEMA3C,TCF4,TCF7L1,TCF7L2,YES1	
HOTAIR Regulatory Pathway	4.18E00	1.17E-01	2.524	AGO1,AGO3,AKT3,ATXN1,CREBBP,JARID2,KMT2C,LEF1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTEN,ROCK1,STAT3,TCF4,TCF7L1,TCF7L2,XIAP	
GNRH Signaling	4.18E00	1.1E-01	4.243	ADCY9,CACNA1A,CREB3L2,CREBBP,GNAQ,GNG12,ITPR1,ITPR2,ITPR3,MAP2K4,MAP3K1,MAP3K2,MAP3K3,PLCB1,PLCB4,PRKCE,PRKCH,PRKCI,PRKD3,PTK2,SOS2	
Apelin Cardiomyocyte Signaling Pathway	4.13E00	1.41E-01	3.742	AKT3,ARNT,ITPR1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3	
SUMOylation of transcription cofactors	4.1E00	2.05E-01	3.000	CREBBP,HIPK2,NCOA1,NCOA2,PHC3,PIAS1,PIAS2,SCMH1,SIN3A	
GDNF Family Ligand-Receptor Interactions	4.09E00	1.58E-01	2.828	FRS2,GAB1,ITPR1,ITPR2,ITPR3,MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,SOS2	
Endothelin-1 Signaling	4.09E00	1.08E-01	4.025	ADCY9,BRAF,ECE1,GAB1,GNAQ,ITPR1,ITPR2,ITPR3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLA2G4A,PLCB1,PLCB4,PLCG1,PLD1,PRKCE,PRKCH,PRKCI,PRKD3	
Tight Junction Signaling	4.08E00	1.11E-01	NaN	AFDN,AKT3,CTNNA1,EPB41,IGSF5,MYH10,MYH9,MYO10,MYO18A,PARD3,PPM1L,PPP2R5E,PRKCI,PTEN,SMURF1,SPTAN1,TGFB2,TGFBR2,TJP1,VTI1A	
Neuropathic Pain Signaling in Dorsal Horn Neurons	4.04E00	1.39E-01	3.742	ITPR1,ITPR2,ITPR3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3	
GP6 Signaling Pathway	4.02E00	1.26E-01	3.873	AKT3,ITPR1,LAMA3,LAMA4,LAMB2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,PTK2,TLN1	
FOXO-mediated transcription	4.01E00	3.16E-01	2.449	AKT3,CREBBP,FOXO1,FOXO3,KAT2B,SIRT1	
Effects of PIP2 hydrolysis	3.99E00	2.59E-01	2.646	DGKE,DGKH,ITPR1,ITPR2,ITPR3,PRKCE,PRKCH	
Neurotrophin/TRK Signaling	3.98E00	1.54E-01	3.162	CREB3L2,CREBBP,FRS2,GAB1,MAP2K4,MAP2K5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,SOS2	
FLT3 Signaling	3.97E00	2.22E-01	2.828	ABL2,AKT3,CBL,FOXO3,GAB2,PIK3CA,PIK3R1,PTPRJ	
mTOR Signaling	3.92E00	1.03E-01	3.638	AKT3,EIF4G1,EIF4G3,INSR,MAPKAP1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLD1,PPM1L,PPP2R5E,PRKCE,PRKCH,PRKCI,PRKD3,RICTOR,RPS6KA3,RPS6KA5,RPTOR,VEGFC,VEGFD	
Role of Osteoblasts in Rheumatoid Arthritis Signaling Pathway	3.92E00	9.84E-02	-1.528	ACVR1,AKT3,APC,BMPR2,CSNK1G1,FZD6,IGF1R,LEF1,LRP5,LRP6,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SMAD5,SMURF1,SMURF2,STAT3,TCF4,TCF7L1,TCF7L2,TGFB2,VEGFC,VEGFD	
ERBB4 Signaling	3.9E00	1.62E-01	3.162	PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,SOS2,YAP1	
Fc Epsilon RI Signaling	3.85E00	1.27E-01	3.357	AKT3,GAB1,INPP5F,MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLA2G4A,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,SOS2	
Ephrin Receptor Signaling	3.84E00	1.04E-01	3.464	AKT3,CREB3L2,CREBBP,EFNB2,EPHA3,EPHA4,GNAQ,GNG12,ITGA1,KALRN,MAP4K4,PDGFD,PTK2,RAPGEF1,ROCK1,SORBS1,SOS2,STAT3,VEGFC,VEGFD,WIPF1	
Synaptic Long Term Potentiation	3.82E00	1.21E-01	3.357	CREB3L2,CREBBP,GNAQ,ITPR1,ITPR2,ITPR3,PLCB1,PLCB4,PLCG1,PPP1R12A,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3	
Activin Inhibin Signaling Pathway	3.8E00	1.01E-01	3.411	ACVR1,AKT3,CREBBP,FOXO3,LEF1,LIPE,MAP2K4,MAP2K5,MAP3K1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,ROCK1,SKI,SMAD5,STAT3,TCF4,TCF7L1,TCF7L2,TGFB2,TGFBR3	
GM-CSF Signaling	3.78E00	1.57E-01	2.333	AKT3,BCL2L1,ETS1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,PPP3CC,SOS2,STAT3	
PI Metabolism	3.77E00	1.46E-01	3.464	INPP5F,MTMR3,PI4KA,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PIKFYVE,PIP4K2A,PLEKHA5,PTEN,SBF2	
BEX2 Signaling Pathway	3.77E00	1.46E-01	2.111	AKT3,LEF1,MAP2K4,PPM1L,PPP2R5E,PTEN,STAT3,TCF4,TCF7L1,TCF7L2,VEGFC,VEGFD	
Erythropoietin Signaling Pathway	3.74E00	1.08E-01	3.441	AKT3,ARNT,BCL2L1,FOXO3,ITPR1,ITPR2,ITPR3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,SOS2,TGFB2,XIAP	
Telomerase Signaling	3.72E00	1.3E-01	2.333	AKT3,ELF2,ETS1,HDAC4,HDAC7,HDAC8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP2R5E,RB1,SOS2	
Sertoli Cell-Germ Cell Junction Signaling Pathway (Enhanced)	3.72E00	9.75E-02	0.626	AFDN,AKT3,CTNNA1,IGSF5,LAMA3,LAMA4,LAMB2,MAP2K4,MAP3K1,MAP3K2,MAP3K3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP2R5E,PRKG1,PTK2,SORBS1,TGFB2,TGFBR2,TJP1	
Signaling by Rho Family GTPases	3.72E00	9.36E-02	3.578	ARHGEF10,ARHGEF11,ARHGEF12,ARHGEF3,ARHGEF9,CDH13,GNAQ,GNG12,ITGA1,MAP2K4,MAP3K20,PARD3,PI4KA,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PIKFYVE,PIP4K2A,PLD1,PPP1R12A,PRKCI,PTK2,ROCK1,WIPF1	
Endometrial Cancer Signaling	3.7E00	1.67E-01	1.414	AKT3,CTNNA1,FOXO3,LEF1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTEN,SOS2	
Transcriptional regulation by RUNX3	3.69E00	1.35E-01	3.162	CREBBP,FOXO3,HDAC4,KAT2B,LEF1,MAML3,SMURF1,SMURF2,TCF7L1,TCF7L2,WWTR1,YAP1,ZFHX3	
PEDF Signaling	3.67E00	1.43E-01	2.309	AKT3,BCL2L1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,ROCK1,TCF12,TCF4,TCF7L1,TCF7L2,ZEB1	
Transcriptional Regulatory Network in Embryonic Stem Cells	3.66E00	1.1E-01	3.300	ACVR1,AKT3,BMPR2,FZD6,IGF1R,KAT6A,LIFR,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SMAD5,STAT3,TCF7L1,TGFB2,TGFBR2,TGFBR3,ZFHX3	
Cellular Effects of Sildenafil (Viagra)	3.66E00	1.13E-01	NaN	ADCY9,CACNA1A,ITPR1,ITPR2,ITPR3,MPRIP,MYH10,MYH9,MYO10,MYO18A,PDE5A,PLCB1,PLCB4,PLCG1,PPP1R12A,Ppp1r12b,PRKG1	
Clathrin-mediated Endocytosis Signaling	3.66E00	1.01E-01	NaN	AAK1,AP1G1,AP3B1,CBL,CLTC,DNM3,GAK,HIP1,MYO1E,MYO6,PDGFD,PICALM,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,PPP3CC,USP9X,VEGFC,VEGFD	
3-phosphoinositide Biosynthesis	3.66E00	1.01E-01	4.123	INPP5F,PI4KA,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PIKFYVE,PIP4K2A,PPM1H,PPM1L,PPP1R12A,PPP1R16B,PPP2R5E,PPP3CA,PPP3CC,PTEN,PTPRJ,PTPRM,RNGTT,SGPP2,SSH2	
Acetylcholine Receptor Signaling Pathway	3.63E00	1.03E-01	4.472	ADCY9,AKT3,CACNA1A,CREB3L2,CREBBP,GNAQ,ITPR1,ITPR2,ITPR3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3	
Transcriptional Regulation by VENTX	3.63E00	2E-01	-0.816	AGO1,AGO3,ANAPC1,EHMT1,LEF1,TCF7L2,TNRC6B,TNRC6C	
Colorectal Cancer Metastasis Signaling	3.62E00	9.23E-02	3.900	ADCY9,AKT3,APC,BCL2L1,BRAF,FZD6,GNAQ,GNG12,LEF1,LRP5,LRP6,MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SOS2,STAT3,TCF4,TCF7L1,TCF7L2,TGFB2,TGFBR2,VEGFC,VEGFD	
Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency	3.61E00	1.21E-01	3.000	ACVR1,AKT3,APC,BMPR2,FZD6,GAB1,LIFR,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SMAD5,SOS2,STAT3,TCF7L1	
p53 Signaling	3.6E00	1.33E-01	-0.577	AKT3,BCL2L1,HIPK2,KAT2B,PIAS1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTEN,RB1,SIRT1,STAG1	
UVA-Induced MAPK Signaling	3.6E00	1.33E-01	3.000	BCL2L1,MAP2K4,PARP14,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,RPS6KA3,RPS6KA5,TNKS	
Transcriptional regulation by RUNX1	3.59E00	1.12E-01	4.123	ARID1A,ARID1B,ARID2,CREBBP,ELF2,HIPK2,LIFR,PBRM1,PHC3,PSME4,SCMH1,SMARCA2,SMARCA4,SMARCC2,TCF12,TJP1,YAP1	
Protein Ubiquitination Pathway	3.57E00	9.16E-02	NaN	ANAPC1,BIRC6,BTRC,CBL,DNAJC1,DNAJC13,DNAJC5,FBXW7,HLA-A,NEDD4L,PRKN,SMURF1,SMURF2,UBE3A,UBR1,USP15,USP24,USP25,USP32,USP34,USP40,USP47,USP54,USP9X,XIAP	
Type II Diabetes Mellitus Signaling	3.56E00	1.11E-01	2.887	ADIPOR2,AKT3,CACNA1A,INSR,ITPR1,ITPR2,ITPR3,MAP2K4,MAP3K1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCE,PRKCH,PRKCI,PRKD3	
RET signaling	3.55E00	1.95E-01	2.828	FRS2,GAB1,GAB2,PIK3CA,PIK3R1,PIK3R3,PLCG1,SHANK3	
YAP1- and WWTR1 (TAZ)-stimulated gene expression	3.54E00	3.33E-01	2.236	HIPK1,HIPK2,KAT2B,WWTR1,YAP1	
HIPPO signaling	3.52E00	1.38E-01	-0.816	BTRC,DLG1,FAT4,NF2,PARD3,PPM1L,PPP1R12A,PPP2R5E,SMAD5,STK3,WWTR1,YAP1	
PDGF Signaling	3.52E00	1.38E-01	3.464	ABL2,INPP5F,MAP2K4,MAP3K1,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,SOS2,STAT3	
PIP3 activates AKT signaling	3.52E00	1.14E-01	4.000	AKT3,FOXO1,FOXO3,FRS2,GAB1,GAB2,INSR,MAPKAP1,PHLPP1,PIK3CA,PIK3R1,PIK3R3,PIP4K2A,PPP2R5E,PTEN,RICTOR	
TCF dependent signaling in response to WNT	3.49E00	1.01E-01	4.472	APC,BTRC,CDC73,CREBBP,FZD6,KMT2D,LEF1,LRP5,LRP6,PPP2R5E,PSME4,SMARCA4,SMURF2,TCF4,TCF7L1,TCF7L2,TNKS,USP34,XIAP,ZNRF3	
Formation of WDR5-containing histone-modifying complexes	3.48E00	1.9E-01	2.828	BOD1L1,KANSL1,KAT2B,KDM6A,KMT2C,KMT2D,OGT,ZZZ3	
Leptin Signaling in Obesity	3.46E00	1.45E-01	1.890	ADCY9,AKT3,FOXO1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,STAT3	
Macropinocytosis Signaling	3.46E00	1.45E-01	3.000	PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,USP6NL	
TR/RXR Activation	3.46E00	1.17E-01	3.357	ACACA,AKT3,NCOA1,NCOA2,NCOR1,NRF1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RCAN2,SLC16A2,STRBP,VEGFC,VEGFD	
Signaling by TGF-beta Receptor Complex	3.45E00	1.7E-01	3.000	CBL,NEDD4L,PARD3,SMURF1,SMURF2,TGFB2,TGFBR2,USP15,ZFYVE9	
Xenobiotic Metabolism General Signaling Pathway	3.42E00	1.12E-01	4.000	AKT3,ARNT,CREBBP,MAP2K4,MAP2K5,MAP3K1,MAP3K2,MAP3K3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCE,PRKCH,PRKCI,PRKD3	
Signaling by SCF-KIT	3.4E00	1.86E-01	2.828	CBL,FER,GAB2,PIK3CA,PIK3R1,PIK3R3,STAT3,YES1	
Opioid Signalling	3.38E00	1.33E-01	3.000	ADCY9,GNAQ,GNG12,ITPR1,ITPR2,ITPR3,NBEA,PLA2G4A,PLCB1,PLCB4,PPP3CA,PPP3CC	
Signaling by NOTCH1	3.36E00	1.41E-01	3.317	CREBBP,FBXW7,HDAC4,HDAC7,HDAC8,KAT2B,MAML3,MIB1,NBEA,NCOR1,TBL1X	
RHOGDI Signaling	3.33E00	9.55E-02	-2.673	ARHGAP35,ARHGAP5,ARHGEF10,ARHGEF11,ARHGEF12,ARHGEF3,ARHGEF9,CDH13,CREBBP,GNAQ,GNG12,ITGA1,MYH10,MYH9,MYO10,MYO18A,PI4KA,PIKFYVE,PIP4K2A,PPP1R12A,ROCK1	
Oncogene Induced Senescence	3.32E00	2.06E-01	-1.134	AGO1,AGO3,CDK6,ETS1,RB1,TNRC6B,TNRC6C	
Virus Entry via Endocytic Pathways	3.32E00	1.19E-01	NaN	AP1G1,AP3B1,CLTC,FLNB,HLA-A,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3	
GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells	3.32E00	1.19E-01	3.742	ADCY9,CACNA1A,GNAQ,GNG12,ITPR1,ITPR2,ITPR3,PLCB1,PLCB4,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3	
Osteoarthritis Pathway	3.32E00	9.32E-02	2.524	ANKH,BMPR2,CREB3L2,CREBBP,CTNNA1,EPAS1,FN1,FOXO3,FZD6,HDAC4,ITGA1,LEF1,MEF2C,SIK3,SIRT1,SMAD5,TCF4,TCF7L1,TCF7L2,TGFBR2,VEGFC,VEGFD	
Renal Cell Carcinoma Signaling	3.31E00	1.39E-01	3.000	AKT3,ARNT,CREBBP,ETS1,GAB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RAPGEF1,SOS2	
CSDE1 Signaling Pathway	3.27E00	1.61E-01	1.134	AGO1,AGO3,AKT3,CSDE1,DDX6,FN1,HNRNPC,PTEN,TRIO	
ERBB Signaling	3.25E00	1.29E-01	2.887	FOXO1,MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,SOS2	
Cell Cycle: G1/S Checkpoint Regulation	3.2E00	1.45E-01	-0.378	BTRC,CDK6,FOXO1,HDAC4,HDAC7,HDAC8,RB1,RBL2,SIN3A,TGFB2	
D-myo-inositol (1,4,5)-Trisphosphate Biosynthesis	3.2E00	2.31E-01	2.449	PI4KA,PIKFYVE,PIP4K2A,PLCB1,PLCB4,PLCG1	
Dilated Cardiomyopathy Signaling Pathway	3.19E00	1.07E-01	-0.905	ADCY9,AKT3,CACNA1A,GAB1,ITPR1,ITPR2,ITPR3,KDM5A,LAMA4,MAP3K3,MYH10,MYH9,MYO10,MYO18A,PRKCE,UTRN	
PTEN Regulation	3.19E00	1.07E-01	2.828	AGO1,AGO3,AKT3,CHD4,HDAC7,MECOM,PHC3,PREX2,PSME4,PTEN,RPTOR,SCMH1,TNKS,TNRC6B,TNRC6C,XIAP	
JAK/STAT Signaling	3.17E00	1.34E-01	2.111	AKT3,BCL2L1,GNAQ,PIAS1,PIAS2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SOS2,STAT3	
Prolactin Signaling	3.17E00	1.26E-01	3.317	CREBBP,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,SOS2,STAT3	
Cancer Drug Resistance by Drug Efflux	3.15E00	1.55E-01	2.828	ABCB1,AKT3,BRAF,FOXO1,FOXO3,PIK3CA,PIK3R1,PIK3R3,PTEN	
Autism Signaling Pathway	3.15E00	8.44E-02	3.400	AKT3,APC,BRAF,CACNA1A,CREBBP,FZD6,HLA-A,IGF1R,LEF1,LRP5,LRP6,NF1,PCCA,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTEN,RPTOR,SHANK3,SOS2,TCF4,TCF7L1,TCF7L2,TGFB2,UBE3A	
Ephrin A Signaling	3.13E00	1.7E-01	NaN	EPHA3,EPHA4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,ROCK1	
TGF-Î² Signaling	3.13E00	1.25E-01	1.265	ACVR1,BMPR2,CREBBP,MAP2K4,SKI,SMAD5,SMURF1,SMURF2,SOS2,TGFB2,TGFBR2,ZFYVE9	
Corticotropin Releasing Hormone Signaling	3.12E00	1.05E-01	2.714	ADCY9,BRAF,CACNA1A,CREB3L2,CREBBP,GNAQ,ITPR1,ITPR2,ITPR3,MEF2C,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,SMARCC2	
BMAL1:CLOCK,NPAS2 activates circadian gene expression	3.1E00	2.22E-01	2.449	CHD9,CREBBP,DBP,NCOA1,NCOA2,TBL1X	
Cardiac Hypertrophy Signaling	3.1E00	8.81E-02	4.583	ADCY9,CACNA1A,CREBBP,GNAQ,GNG12,IGF1R,MAP2K4,MAP3K1,MAP3K2,MAP3K3,MEF2C,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,ROCK1,TGFB2,TGFBR2	
Polyamine Regulation in Colon Cancer	3.1E00	1.53E-01	2.333	AKT3,APC,BRAF,MAP2K4,MAP2K5,RPTOR,STIM1,TCF4,TCF7L2	
D-myo-inositol-5-phosphate Metabolism	3.1E00	9.6E-02	3.873	INPP5F,PIKFYVE,PIP4K2A,PLCB1,PLCB4,PLCG1,PPM1H,PPM1L,PPP1R12A,PPP1R16B,PPP2R5E,PPP3CA,PPP3CC,PTEN,PTPRJ,PTPRM,RNGTT,SGPP2,SSH2	
Oxytocin in Brain Signaling Pathway	3.07E00	9.55E-02	4.243	AKT3,CACNA1A,CREB3L2,CREBBP,GNAQ,GNG12,ITPR1,ITPR2,ITPR3,MEF2C,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLA2G4A,PRKCE,PRKCH,PRKCI,PRKD3	
Deubiquitination	3.06E00	8.75E-02	4.796	APC,ASXL2,ATXN7,BABAM2,IDE,INO80D,KAT2B,MBD5,OGT,OTUD7B,PRKN,PSME4,PTEN,SMURF2,TGFBR2,TNKS,TRIM25,USP15,USP24,USP25,USP34,USP47,USP9X	
Signaling by ALK	3.01E00	2.14E-01	1.633	FRS2,PIK3CA,PIK3R1,PLCG1,SIN3A,STAT3	
Endocannabinoid Developing Neuron Pathway	3E00	1.1E-01	2.887	ADCY9,AKT3,BRAF,CREB3L2,CREBBP,GNG12,MAP2K4,MAP2K5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RPTOR,STAT3	
Platelet homeostasis	3E00	1.28E-01	3.317	ATP2B4,GNG12,ITPR1,ITPR2,ITPR3,LRP8,PDE5A,PLA2G4A,PPP2R5E,PRKG1,STIM1	
Cyclins and Cell Cycle Regulation	3E00	1.28E-01	-1.000	BTRC,CDK6,HDAC4,HDAC7,HDAC8,PPM1L,PPP2R5E,RB1,RBL2,SIN3A,TGFB2	
Fcgamma receptor (FCGR) dependent phagocytosis	2.97E00	1.02E-01	3.606	DOCK1,ELMO1,ITPR1,ITPR2,ITPR3,MYH9,MYO10,NCKAP1,NF2,PIK3CA,PIK3R1,PLCG1,PRKCE,PTK2,WIPF1,YES1	
p75 NTR receptor-mediated signalling	2.97E00	1.2E-01	3.464	AKAP13,ARHGEF10,ARHGEF11,ARHGEF12,ARHGEF3,ARHGEF9,KALRN,MCF2L,PRKCI,RASGRF2,SOS2,TRIO	
Mitotic Prometaphase	2.97E00	9.36E-02	4.359	CENPC,CKAP5,CLASP1,CLASP2,DYNC1H1,EML4,HDAC8,MAD1L1,NEK7,NEK9,PCM1,PDS5A,PDS5B,PPP2R5E,RAD21,SDCCAG8,SMC1A,STAG1,TAOK1	
Cachexia Signaling Pathway	2.96E00	7.88E-02	1.300	ACVR1,ADCY9,AGO1,AGO3,AKT3,BMPR2,FOXO1,FOXO3,IGF1R,INSR,LIFR,LIPE,MAP2K4,MEF2C,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCE,PRKCH,PRKCI,PRKD3,PSME4,PTEN,SIRT1,STAT3,TGFB2,TGFBR2,TGFBR3	
trans-Golgi Network Vesicle Budding	2.96E00	1.35E-01	3.162	AP1G1,AP3B1,APP,CLTC,CPD,GAK,GOLGB1,PICALM,PIK3C2A,SORT1	
Signaling by ERBB2	2.95E00	1.6E-01	2.828	AKT3,ERBIN,GAB1,PIK3CA,PIK3R1,PLCG1,PRKCE,YES1	
NR1H2 and NR1H3-mediated signaling	2.95E00	1.6E-01	0.000	AGO1,AGO3,KDM3A,NCOA1,NCOR1,TBL1X,TNRC6B,TNRC6C	
Melanoma Signaling	2.95E00	1.6E-01	1.890	AKT3,BRAF,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTEN,RB1	
FAT10 Cancer Signaling Pathway	2.95E00	1.6E-01	2.646	ACVR1,AKT3,BMPR2,STAT3,TCF7L2,TGFB2,TGFBR2,TGFBR3	
Signaling by Hippo	2.91E00	2.5E-01	2.236	AMOTL1,STK3,TJP1,WWTR1,YAP1	
Signaling by FGFR3	2.88E00	1.75E-01	2.646	BRAF,CBL,FRS2,GAB1,PIK3CA,PIK3R1,PLCG1	
Production of Nitric Oxide and Reactive Oxygen Species in Macrophages	2.87E00	9.42E-02	3.153	AKT3,CREBBP,MAP2K4,MAP3K1,MAP3K2,MAP3K3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPM1L,PPP1R12A,PPP2R5E,PRKCE,PRKCH,PRKCI,PRKD3	
SUMOylation of DNA damage response and repair proteins	2.87E00	1.32E-01	3.162	HDAC7,HERC2,NSMCE2,PHC3,PIAS1,PIAS2,RAD21,SCMH1,SMC1A,STAG1	
Mitochondrial biogenesis	2.84E00	1.41E-01	1.667	CHD9,CREBBP,MEF2C,NCOA1,NCOA2,NCOR1,NR1D1,NRF1,TBL1X	
Leukocyte Extravasation Signaling	2.82E00	9.33E-02	2.828	AFDN,ARHGAP35,ARHGAP5,CTNNA1,FER,MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,PTK2,ROCK1,WIPF1	
RAR Activation	2.82E00	7.46E-02	4.243	ACVR1,ADCY9,AKT3,ARID1A,ARID2,BMPR2,CREB3L2,CREBBP,GNAQ,KAT2B,LIPE,MAP2K4,MAP3K1,NCOA1,NCOR1,PBRM1,PDE5A,PDE7B,PDE8A,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTEN,RAB11FIP3,RPS6KA5,SMARCA2,SMARCA4,SMARCC2,TGFB2,TGFBR2,TGFBR3	
DAG and IP3 signaling	2.81E00	1.71E-01	2.000	ADCY9,ITPR1,ITPR2,ITPR3,NBEA,PLCG1,PRKCE	
Signaling by FGFR4	2.81E00	1.71E-01	2.646	BRAF,CBL,FRS2,GAB1,PIK3CA,PIK3R1,PLCG1	
Interleukin-7 signaling	2.8E00	2.38E-01	2.236	BRWD1,PIK3R1,PIK3R3,SMARCA4,STAT3	
NAFLD Signaling Pathway	2.79E00	8.85E-02	1.342	ACACA,ACACB,AKT3,ATF6,CPT1A,FOXO1,FOXO3,INSR,LIPE,MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP2R5E,PRKCE,RPTOR,STAT3,TGFB2	
Pyridoxal 5'-phosphate Salvage Pathway	2.79E00	1.38E-01	3.000	BRAF,CDK6,DYRK1A,GRK5,HIPK1,MAP2K4,PDXK,PRKCE,PRKCH	
IGF-1 Signaling	2.78E00	1.14E-01	3.162	AKT3,FOXO1,FOXO3,IGF1R,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCI,PTK2,SOS2,STAT3	
VDR/RXR Activation	2.78E00	1.28E-01	-1.890	FOXO1,LRP5,NCOA1,NCOA2,NCOR1,PRKCE,PRKCH,PRKCI,PRKD3,TGFB2	
NF-ÎºB Activation by Viruses	2.78E00	1.28E-01	3.162	AKT3,MAP3K1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCE,PRKCH,PRKCI,PRKD3	
IL-7 Signaling Pathway	2.78E00	1.28E-01	2.828	AKT3,EBF1,FOXO1,FOXO3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,SOS2	
Signaling by CSF1 (M-CSF) in myeloid cells	2.77E00	1.94E-01	2.449	CBL,GAB2,PIK3CA,PIK3R1,STAT3,YES1	
Sphingosine-1-phosphate Signaling	2.75E00	1.08E-01	2.887	ACER2,ADCY9,AKT3,GNAQ,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PTK2	
Paxillin Signaling	2.71E00	1.12E-01	3.317	DOCK1,GIT2,ITGA1,MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,SOS2,TLN1,TLN2	
PD-1, PD-L1 cancer immunotherapy pathway	2.71E00	1.12E-01	-1.508	AKT3,BCL2L1,CBLB,HLA-A,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PTEN,TGFB2,YAP1	
Synaptic Long Term Depression	2.7E00	9.09E-02	3.500	CACNA1A,GNAQ,IGF1R,ITPR1,ITPR2,ITPR3,PLA2G4A,PLCB1,PLCB4,PLCG1,PPM1L,PPP2R5E,PRKCE,PRKCH,PRKCI,PRKD3,PRKG1,SMARCC2	
Role of BRCA1 in DNA Damage Response	2.7E00	1.25E-01	NaN	ARID1A,ARID2,BABAM2,PBRM1,POU2F1,RB1,RBL2,SMARCA2,SMARCA4,SMARCC2	
EPH-Ephrin signaling	2.68E00	1.17E-01	3.317	ARHGEF28,CLTC,EFNB2,EPHA3,EPHA4,KALRN,MYH10,MYH9,PTK2,ROCK1,YES1	
Interleukin-3, Interleukin-5 and GM-CSF signaling	2.68E00	1.45E-01	2.828	CBL,GAB2,INPP5F,PIK3CA,PIK3R1,PIK3R3,RAPGEF1,YES1	
Î±-Adrenergic Signaling	2.64E00	1.1E-01	3.162	ADCY9,GNAQ,GNG12,ITPR1,ITPR2,ITPR3,PHKB,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3	
Germ Cell-Sertoli Cell Junction Signaling	2.61E00	9.41E-02	NaN	AFDN,CTNNA1,FER,MAP2K4,MAP3K1,MAP3K2,MAP3K3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,SORBS1,TGFB2,TGFBR2,TJP1	
CNTF Signaling	2.57E00	1.4E-01	2.828	LIFR,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RPS6KA3,RPS6KA5,STAT3	
Calcium Signaling	2.56E00	8.64E-02	3.162	ATP2B4,CACNA1A,CREB3L2,CREBBP,HDAC4,HDAC7,HDAC8,ITPR1,ITPR2,ITPR3,MEF2C,MYH10,MYH9,MYO10,MYO18A,NFAT5,PPP3CA,PPP3CC,RCAN2	
Melanocyte Development and Pigmentation Signaling	2.53E00	1.12E-01	3.162	ADCY9,CREB3L2,CREBBP,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,RPS6KA3,RPS6KA5,SOS2	
Regulation of RUNX1 Expression and Activity	2.53E00	2.08E-01	NaN	AGO1,AGO3,CDK6,TNRC6B,TNRC6C	
RUNX1 regulates megakaryocyte differentiation and platelet function	2.53E00	1.38E-01	2.646	AGO1,AGO3,KAT2B,KMT2C,KMT2D,SIN3A,TNRC6B,TNRC6C	
Translocation of SLC2A4 (GLUT4) to the plasma membrane	2.52E00	1.27E-01	3.000	EXOC2,EXOC4,EXOC6,LNPEP,MYH9,RAB10,RALGAPA2,RALGAPB,TBC1D4	
IL-23 Signaling Pathway	2.52E00	1.52E-01	2.646	AKT3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RORA,STAT3	
Transcriptional Regulation by NPAS4	2.49E00	1.71E-01	-0.816	AGO1,AGO3,ARNT,CREBBP,TNRC6B,TNRC6C	
G Beta Gamma Signaling	2.48E00	1.01E-01	3.162	AKT3,CACNA1A,GNAQ,GNG12,ITPR1,ITPR2,ITPR3,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,SOS2	
ATM Signaling	2.47E00	1.1E-01	0.000	CBX5,CREB3L2,CREBBP,HERC2,MAP2K4,PPM1L,PPP2R5E,SMC1A,TLK1,TLK2,ZEB1	
Signaling by NTRK2 (TRKB)	2.45E00	2E-01	2.236	FRS2,GAB1,PIK3CA,PIK3R1,PLCG1	
Signaling by Erythropoietin	2.45E00	2E-01	2.236	GAB1,PIK3CA,PIK3R1,PLCG1,RAPGEF1	
Xenobiotic Metabolism Signaling	2.43E00	7.82E-02	NaN	ABCB1,ARNT,CHST11,CREBBP,HDAC4,MAOA,MAP2K4,MAP2K5,MAP3K1,MAP3K2,MAP3K3,NCOA1,NDST1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP2R5E,PRKCE,PRKCH,PRKCI,PRKD3	
IL-13 Signaling Pathway	2.42E00	1.03E-01	3.464	AKT3,BCL2L1,FAM120A,MAOA,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,ROCK1,STAT3,TGFB2,YES1	
Tumor Microenvironment Pathway	2.39E00	8.94E-02	2.500	AKT3,BRAF,FN1,FOXO1,FOXO3,HLA-A,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SLC16A1,STAT3,TGFB2,VEGFC,VEGFD	
Neuregulin Signaling	2.39E00	1.03E-01	2.530	AKT3,ERBIN,ITGA1,PIK3R1,PIK3R3,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,PTEN,SOS2	
RAF/MAP kinase cascade	2.39E00	8.02E-02	4.583	BRAF,DLG1,FN1,FRS2,IL17RD,KSR1,NF1,PIK3CA,PIK3R1,PPP2R5E,PSME4,PTK2,RANBP9,RAPGEF2,RASAL2,RASGRF2,SPTAN1,SPTBN1,TEK,TLN1,VWF	
Signaling by BMP	2.37E00	1.92E-01	2.236	BMPR2,SKI,SMAD5,SMURF1,SMURF2	
ESR-mediated signaling	2.36E00	1.02E-01	1.155	AGO1,AGO3,CREBBP,KAT2B,NCOA1,NCOA2,POU2F1,RAD21,SMC1A,STAG1,TNRC6B,TNRC6C	
PFKFB4 Signaling Pathway	2.36E00	1.43E-01	2.449	CREB3L2,CREBBP,MAP2K4,MAP2K5,RPS6KA5,TGFB2,XDH	
RAB GEFs exchange GTP for GDP on RABs	2.35E00	1.12E-01	3.162	AKT3,DENND1A,DENND1B,DENND4C,GAPVD1,RAB10,RIC1,RIN2,SBF2,TRAPPC9	
Cytoprotection by HMOX1	2.34E00	1.29E-01	2.828	CHD9,CREBBP,NCOA1,NCOA2,NCOR1,SIN3A,STAT3,TBL1X	
Neuroinflammation Signaling Pathway	2.33E00	7.57E-02	2.985	ACVR1,AKT3,APP,BIRC6,BMPR2,CREB3L2,CREBBP,HLA-A,IDE,IRAK3,MAP2K4,NFAT5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLA2G4A,PLCG1,PPP3CA,PPP3CC,TGFB2,TGFBR2,TGFBR3,XIAP	
Pre-NOTCH Expression and Processing	2.32E00	1.18E-01	2.236	AGO1,AGO3,CREBBP,KAT2B,MAML3,NOTCH4,PRKCI,TNRC6B,TNRC6C	
Angiopoietin Signaling	2.32E00	1.18E-01	2.000	AKT3,FOXO1,GRB14,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,TEK	
Signaling by FGFR1	2.31E00	1.4E-01	2.646	BRAF,CBL,FRS2,GAB1,PIK3CA,PIK3R1,PLCG1	
STAT3 Pathway	2.31E00	9.63E-02	3.464	BMPR2,FLT1,FLT4,GHR,IGF1R,IL17RD,INSR,MAP2K4,MAP3K20,STAT3,TGFB2,TGFBR2,TGFBR3	
Ceramide Signaling	2.29E00	1.1E-01	-0.333	AKT3,KSR1,MAP2K4,MAP3K1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP2R5E	
PI3K/AKT Signaling	2.28E00	8.5E-02	-0.333	AKT3,BCL2L1,FOXO1,FOXO3,GAB1,GAB2,GHR,IL17RD,INPP5F,ITGA1,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP2R5E,PTEN,SOS2	
Biotin-carboxyl Carrier Protein Assembly	2.28E00	6.67E-01	NaN	ACACA,ACACB	
Role of WNT/GSK-3Î² Signaling in the Pathogenesis of Influenza	2.25E00	1.15E-01	NaN	APC,CSNK1G1,FZD6,LEF1,NCOA1,NCOA2,TCF4,TCF7L1,TCF7L2	
White Adipose Tissue Browning Pathway	2.23E00	9.42E-02	2.121	ADCY9,CACNA1A,CREB3L2,CREBBP,ITPR1,ITPR2,ITPR3,LIPE,NRF1,PRKG1,RUNX1T1,SIRT1,SLC16A1	
SUMOylation of intracellular receptors	2.23E00	1.79E-01	2.236	HDAC4,NR3C2,PIAS1,PIAS2,RORA	
Intra-Golgi and retrograde Golgi-to-ER traffic	2.22E00	8.37E-02	4.123	COG5,CYTH3,DYNC1H1,GOLGA4,GOLIM4,KIF13B,KIF16B,KIF1B,KIF1C,MAN1A1,NBAS,PLA2G4A,RIC1,TRIP11,USP6NL,VPS54,VTI1A	
ERB2-ERBB3 Signaling	2.22E00	1.23E-01	1.414	FOXO1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTEN,SOS2,STAT3	
Role of JAK family kinases in IL-6-type Cytokine Signaling	2.21E00	1.14E-01	2.333	BCL2L1,LIFR,MAP2K4,OSMR,PIAS1,STAT3,TGFB2,VEGFC,VEGFD	
Cilium Assembly	2.2E00	8.33E-02	4.123	ASAP1,BBS9,C2CD3,CEP83,CKAP5,CLASP1,DYNC1H1,EXOC2,EXOC4,EXOC6,PCM1,PKD1,PKD2,RAB11FIP3,SDCCAG8,TRIP11,TTBK2	
WNT/Ca+ pathway	2.18E00	1.21E-01	2.646	CREB3L2,CREBBP,FZD6,NFAT5,PLCB1,PLCB4,PLCG1,PPP3CA	
Activation of gene expression by SREBF (SREBP)	2.14E00	1.46E-01	2.449	ACACB,CHD9,CREBBP,NCOA1,NCOA2,TBL1X	
IL-17A Signaling in Airway Cells	2.14E00	1.19E-01	2.121	AKT3,MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTEN,STAT3	
RHO GTPases Activate ROCKs	2.13E00	2.11E-01	2.000	MYH10,MYH9,PPP1R12A,ROCK1	
Role of p14/p19ARF in Tumor Suppression	2.1E00	1.67E-01	-1.342	PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RB1	
3-phosphoinositide Degradation	2.08E00	8.29E-02	3.464	INPP5F,MTMR3,PIKFYVE,PPM1H,PPM1L,PPP1R12A,PPP1R16B,PPP2R5E,PPP3CA,PPP3CC,PTEN,PTPRJ,PTPRM,RNGTT,SGPP2,SSH2	
Deadenylation-dependent mRNA decay	2.08E00	1.27E-01	2.646	CNOT1,CNOT4,CNOT6L,DDX6,EIF4G1,PAN3,XRN1	
Lymphotoxin Î² Receptor Signaling	2.08E00	1.27E-01	2.236	AKT3,BCL2L1,CREBBP,PIK3C2A,PIK3CA,PIK3R1,PIK3R3	
LPS-stimulated MAPK Signaling	2.01E00	1.06E-01	3.000	MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCE,PRKCH,PRKCI,PRKD3	
S Phase	2E00	1E-01	1.897	AKT3,LIN52,PDS5A,PDS5B,PSME4,RAD21,RB1,RBL2,SMC1A,STAG1	
NR1D1 (REV-ERBA) represses gene expression	1.99E00	5E-01	NaN	NCOR1,NR1D1	
Neurovascular Coupling Signaling Pathway	1.99E00	7.76E-02	1.886	APP,CACNA1A,ENTPD1,GNAQ,ITPR1,ITPR2,ITPR3,MPRIP,PLA2G4A,PLCB1,PLCB4,PPP1R12A,Ppp1r12b,PRKG1,ROCK1,SLC16A1,SMARCC2,STIM1	
Amyotrophic Lateral Sclerosis Signaling	1.99E00	9.48E-02	1.000	AKT3,BCL2L1,CACNA1A,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,VEGFC,VEGFD,XIAP	
RIPK1-mediated regulated necrosis	1.98E00	1.56E-01	2.236	OGT,PDCD6IP,PELI1,PRKN,XIAP	
Oxidative Stress Induced Senescence	1.97E00	1.05E-01	2.236	AGO1,AGO3,CDK6,MAP2K4,MAP4K4,PHC3,SCMH1,TNRC6B,TNRC6C	
RHO GTPases activate PAKs	1.97E00	1.9E-01	2.000	MYH10,MYH9,NF2,PPP1R12A	
D-myo-inositol (1,4,5,6)-Tetrakisphosphate Biosynthesis	1.96E00	8.24E-02	3.317	INPP5F,PIKFYVE,PPM1H,PPM1L,PPP1R12A,PPP1R16B,PPP2R5E,PPP3CA,PPP3CC,PTEN,PTPRJ,PTPRM,RNGTT,SGPP2,SSH2	
D-myo-inositol (3,4,5,6)-tetrakisphosphate Biosynthesis	1.96E00	8.24E-02	3.317	INPP5F,PIKFYVE,PPM1H,PPM1L,PPP1R12A,PPP1R16B,PPP2R5E,PPP3CA,PPP3CC,PTEN,PTPRJ,PTPRM,RNGTT,SGPP2,SSH2	
Endocannabinoid Neuronal Synapse Pathway	1.96E00	8.72E-02	2.333	ADCY9,CACNA1A,DNAH3,GNAQ,GNG12,ITPR1,ITPR2,ITPR3,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC	
Ephrin B Signaling	1.96E00	1.11E-01	2.449	CBL,EFNB2,GNAQ,GNG12,ITSN2,KALRN,PTK2,ROCK1	
Adrenergic Receptor Signaling Pathway (Enhanced)	1.94E00	8E-02	3.500	ADCY9,ATP6V0A1,CACNA1A,GNAQ,ITPR1,ITPR2,ITPR3,MAOA,PLCB1,PLCB4,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,TGFB2	
Signaling by FGFR2	1.92E00	1.1E-01	2.828	BRAF,CBL,FRS2,GAB1,PIK3CA,PIK3R1,PLCG1,RBFOX2	
Extra-nuclear estrogen signaling	1.92E00	1.1E-01	2.828	AKT3,FOXO3,GNG12,IGF1R,PIK3CA,PIK3R1,PIK3R3,PTK2	
Signaling by ERBB4	1.92E00	1.19E-01	2.236	NCOR1,PIK3CA,PIK3R1,TAB2,WWOX,WWP1,YAP1	
Interleukin-2 family signaling	1.9E00	1.3E-01	2.449	GAB2,INPP5F,PIK3CA,PIK3R1,PIK3R3,STAT3	
Androgen Signaling	1.88E00	8.28E-02	2.333	CACNA1A,CREBBP,GNAQ,GNG12,ITPR1,ITPR2,ITPR3,KAT2B,NCOA1,NCOA2,PRKCE,PRKCH,PRKCI,PRKD3	
p38 MAPK Signaling	1.88E00	9.17E-02	3.000	CREB3L2,CREBBP,IRAK3,MAP2K4,MEF2C,PLA2G4A,RPS6KA3,RPS6KA5,TAB2,TGFB2,TGFBR2	
nNOS Signaling in Neurons	1.85E00	1.28E-01	NaN	PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3	
GPCR-Mediated Integration of Enteroendocrine Signaling Exemplified by an L Cell	1.85E00	1.07E-01	0.000	ADCY9,GNAQ,ITPR1,ITPR2,ITPR3,PLCB1,PLCB4,PLCG1	
Phagosome Formation	1.84E00	6.03E-02	6.481	ADGRF5,AKT3,AP1G1,CALCRL,DOCK1,ELMO1,FN1,FZD6,GAB2,ITGA1,ITPR1,ITPR2,ITPR3,MAP2K4,MAP2K5,MYH10,MYH9,MYO10,MYO18A,PI4KA,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PIKFYVE,PIP4K2A,PLA2G4A,PLCG1,PLD1,PRKCE,PRKCH,PRKCI,PRKD3,PTK2,RAPGEF1,ROCK1,SAP130,SOS2,TLN1,TLN2,WIPF1,YES1	
Relaxin Signaling	1.83E00	8.39E-02	2.646	ADCY9,AKT3,BRAF,GNAQ,GNG12,PDE5A,PDE7B,PDE8A,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SMARCC2	
Nephrin family interactions	1.83E00	1.74E-01	2.000	PIK3CA,PIK3R1,SPTAN1,SPTBN1	
Formation of paraxial mesoderm	1.83E00	1.74E-01	2.000	CREBBP,KAT2B,LEF1,MAML3	
IL-9 Signaling	1.81E00	1.43E-01	2.236	PIK3C2A,PIK3CA,PIK3R1,PIK3R3,STAT3	
RHO GTPases Activate Formins	1.81E00	8.63E-02	3.464	CENPC,CKAP5,CLASP1,CLASP2,DYNC1H1,EVL,FMNL2,MAD1L1,PPP2R5E,SCAI,SRGAP2,TAOK1	
Glucocorticoid Receptor Signaling	1.8E00	6.19E-02	NaN	AKT3,ARID1A,ARID2,BCL2L1,CREBBP,DCAF6,DNAH3,FOXO3,GABPB2,GHR,HLA-A,IL17RD,KAT2B,MAP2K4,MAP3K1,NCOA1,NCOA2,NCOR1,NFAT5,NR3C2,PBRM1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLA2G4A,PPP3CA,PPP3CC,RPS6KA5,SMARCA2,SMARCA4,SMARCC2,SOS2,STAT3,TGFB2,TGFBR2	
ABRA Signaling Pathway	1.79E00	9.78E-02	3.000	MAP2K4,MEF2C,MYH9,PPP3CA,PPP3CC,ROCK1,SVIL,VEGFC,VEGFD	
MAPK6/MAPK4 signaling	1.79E00	9.78E-02	0.000	AGO1,AGO3,CDC14A,FOXO1,FOXO3,KALRN,PSME4,TNRC6B,TNRC6C	
G-Protein Coupled Receptor Signaling	1.78E00	5.97E-02	4.529	ADCY9,ADGRF5,AKT3,BRAF,CALCRL,CREB3L2,CREBBP,FOXO1,FOXO3,FZD6,GNAQ,GNG12,GRK5,MAP2K4,MAP2K5,MAP3K1,MAP3K2,MAP3K3,MEF2C,MEGF6,NFAT5,PDE5A,PDE7B,PDE8A,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,PREX2,PRKCE,PTK2,RAPGEF1,ROCK1,SOS2,STAT3,WWTR1,YAP1	
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	1.77E00	1.22E-01	2.449	NCOR1,NEDD4L,SKI,SMURF2,USP9X,WWTR1	
Interleukin-6 family signaling	1.76E00	1.67E-01	2.000	CBL,LIFR,OSMR,STAT3	
Costimulation by the CD28 family	1.76E00	1.03E-01	2.828	AKT3,MAPKAP1,PIK3CA,PIK3R1,PIK3R3,PPP2R5E,RICTOR,YES1	
Interleukin-4 and Interleukin-13 signaling	1.73E00	9.09E-02	3.162	BCL2L1,FN1,FOXO1,FOXO3,MAOA,PIK3R1,POU2F1,RORA,STAT3,ZEB1	
Kinetochore Metaphase Signaling Pathway	1.73E00	9.09E-02	0.333	ANAPC1,CENPC,DNAH3,MAD1L1,PPP1R12A,Ppp2r5c,PPP2R5E,RAD21,SMC1A,STAG1	
Signaling by EGFR	1.73E00	1.2E-01	2.449	CBL,GAB1,PIK3CA,PIK3R1,PLCG1,PTPRK	
Netrin-1 signaling	1.73E00	1.2E-01	2.449	ABLIM1,DOCK1,MYO10,PLCG1,PTK2,TRIO	
ROBO SLIT Signaling Pathway	1.71E00	8.66E-02	-0.905	AKT3,APP,ENAH,FLT1,FLT4,SRGAP1,SRGAP2,TGFBR2,VEGFC,VEGFD,YES1	
Carnitine metabolism	1.71E00	2.14E-01	NaN	ACACA,ACACB,CPT1A	
Interleukin-15 signaling	1.71E00	2.14E-01	NaN	GAB2,SOS2,STAT3	
Protein Sorting Signaling Pathway	1.71E00	7.87E-02	3.742	ADCY9,AP1G1,AP3B1,ARFGEF1,CLTC,GNAQ,GOLGA4,PLD1,SEC24B,SNX13,SNX25,SNX29,SORT1,YES1	
PXR/RXR Activation	1.7E00	1.08E-01	0.378	ABCB1,AKT3,CPT1A,FOXO1,HMGCS2,INSR,NCOA1	
Insulin processing	1.7E00	1.6E-01	2.000	EXOC2,EXOC4,EXOC6,MYRIP	
Transcriptional regulation by RUNX2	1.69E00	1.18E-01	2.449	AKT3,HDAC4,RB1,WWTR1,YAP1,YES1	
UVC-Induced MAPK Signaling	1.69E00	1.18E-01	2.449	BRAF,MAP2K4,PRKCE,PRKCH,PRKCI,PRKD3	
Chemokine Signaling	1.67E00	9.88E-02	0.707	GNAQ,MPRIP,PLCB1,PLCB4,PLCG1,PPP1R12A,Ppp1r12b,PTK2	
Natural Killer Cell Signaling	1.66E00	7.58E-02	3.357	AKT3,HLA-A,MAP3K1,MAP3K2,MAP3K3,MICB,NFAT5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,ROCK1,SOS2,WIPF1	
Salvage Pathways of Pyrimidine Ribonucleotides	1.66E00	9.28E-02	3.000	APOBEC3B,BRAF,CDK6,DYRK1A,GRK5,HIPK1,MAP2K4,PRKCE,PRKCH	
Apoptotic execution phase	1.65E00	1.15E-01	2.449	ADD1,APC,PTK2,ROCK1,SPTAN1,TJP1	
Clathrin-mediated endocytosis	1.65E00	8.46E-02	3.317	AAK1,CBL,CLTC,DNM3,FCHO2,GAK,GAPVD1,HIP1,ITSN2,PICALM,PIK3C2A	
Miscellaneous transport and binding events	1.64E00	1.54E-01	2.000	ADD1,ANKH,LRRC8C,NIPAL3	
Estrogen-Dependent Breast Cancer Signaling	1.64E00	9.76E-02	2.646	AKT3,CREB3L2,CREBBP,IGF1R,PIK3C2A,PIK3CA,PIK3R1,PIK3R3	
Mitotic Metaphase and Anaphase	1.64E00	7.23E-02	4.123	ANAPC1,CENPC,CKAP5,CLASP1,CLASP2,DYNC1H1,HDAC8,LEMD3,MAD1L1,PDS5A,PDS5B,PPP2R5E,PSME4,RAD21,SMC1A,STAG1,TAOK1	
CD40 Signaling	1.64E00	1.04E-01	2.646	MAP2K4,MAP2K5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,STAT3	
Signaling by ROBO receptors	1.59E00	8.62E-02	3.162	ABL2,CLASP1,CLASP2,ENAH,EVL,NRP1,PSME4,SOS2,SRGAP1,SRGAP2	
Integrin signaling	1.59E00	1.48E-01	2.000	FN1,PTK2,TLN1,VWF	
Cardiomyocyte Differentiation via BMP Receptors	1.59E00	1.48E-01	NaN	ACVR1,BMPR2,MEF2C,SMAD5	
GÎ±12/13 Signaling	1.58E00	8.27E-02	2.714	AKT3,CDH13,MAP2K4,MAP3K1,MEF2C,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,ROCK1	
PAK Signaling	1.57E00	8.55E-02	3.000	EPHA3,ITGA1,MAP2K4,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,SOS2	
SUMOylation of DNA methylation proteins	1.55E00	1.88E-01	NaN	DNMT3A,PHC3,SCMH1	
FOXO-mediated transcription of cell death genes	1.55E00	1.88E-01	NaN	CREBBP,FOXO1,FOXO3	
Intrinsic Pathway for Apoptosis	1.55E00	1.09E-01	2.449	AKT3,BCL2L1,PPP3CC,STAT3,UACA,XIAP	
Signaling by PTK6	1.55E00	1.09E-01	2.449	ARHGAP35,CBL,DOCK1,ELMO1,EPAS1,STAT3	
Amino acids regulate mTORC1	1.55E00	1.09E-01	2.449	DEPDC5,FNIP1,FNIP2,RPTOR,SESN1,WDR59	
Hepatic Cholestasis	1.54E00	7.17E-02	1.500	ABCB1,ADCY9,AKT3,FOXO1,INSR,IRAK3,MAP2K4,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,SIRT1,SLCO1C1,TGFB2	
Mechanisms of Viral Exit from Host Cells	1.54E00	1.22E-01	NaN	PDCD6IP,PRKCE,PRKCH,PRKCI,PRKD3	
SUMOylation of chromatin organization proteins	1.51E00	1.07E-01	2.449	CBX5,HDAC4,PHC3,PIAS1,PIAS2,SCMH1	
Cell Cycle Control of Chromosomal Replication	1.51E00	1.07E-01	2.449	CDK12,CDK13,CDK14,CDK19,CDK6,TOP2B	
Integration of energy metabolism	1.51E00	8.74E-02	2.236	ADCY9,ADIPOR2,CACNA1A,GNAQ,GNG12,ITPR1,ITPR2,ITPR3,PLCB1	
Sumoylation Pathway	1.51E00	8.74E-02	-0.707	CREBBP,DNMT3A,ETS1,MAP2K4,PIAS1,SENP2,SIRT1,XIAP,ZEB1	
Regulation of beta-cell development	1.5E00	1.19E-01	2.236	AKT3,CREBBP,FOXO1,KAT2B,MAML3	
DHCR24 Signaling Pathway	1.5E00	8.03E-02	2.714	AKT3,APP,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCE,PRKCH,PRKCI,PRKD3	
Th2 Pathway	1.5E00	8.03E-02	0.905	ACVR1,BMPR2,CHD4,HLA-A,NOTCH4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,TGFBR2,TGFBR3	
Apoptosis Signaling	1.49E00	8.65E-02	-0.707	BCL2L1,BIRC6,MAP2K4,MAP4K4,PLCG1,PRKCE,ROCK1,SPTAN1,XIAP	
Myogenesis	1.48E00	1.38E-01	2.000	CTNNA1,MEF2C,TCF12,TCF4	
EGR2 and SOX10-mediated initiation of Schwann cell myelination	1.48E00	1.38E-01	2.000	SMARCA4,UTRN,WWTR1,YAP1	
TP53 Regulates Metabolic Genes	1.48E00	9.09E-02	0.000	AGO1,AGO3,AKT3,PTEN,RPTOR,SESN1,TNRC6B,TNRC6C	
Neurexins and neuroligins	1.48E00	1.05E-01	2.449	EPB41,EPB41L2,PDLIM5,SHANK3,SIPA1L1,SYT7	
CD27 Signaling in Lymphocytes	1.48E00	1.05E-01	2.449	BCL2L1,MAP2K4,MAP2K5,MAP3K1,MAP3K2,MAP3K3	
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	1.48E00	1.76E-01	NaN	IGF1R,PIK3CA,PIK3R1	
Transcriptional regulation of pluripotent stem cells	1.48E00	1.76E-01	NaN	EPAS1,PBX1,STAT3	
Signaling by NTRK3 (TRKC)	1.48E00	1.76E-01	NaN	PIK3CA,PIK3R1,PLCG1	
FOXO-mediated transcription of cell cycle genes	1.48E00	1.76E-01	NaN	FOXO1,FOXO3,RBL2	
D-myo-inositol (1,3,4)-trisphosphate Biosynthesis	1.48E00	1.76E-01	NaN	INPP5F,ITPKB,PTEN	
Smooth Muscle Contraction	1.46E00	1.16E-01	2.236	DYSF,ITGA1,PDE5A,SORBS1,TLN1	
Signaling by PDGF	1.45E00	1.03E-01	2.449	PDGFD,PIK3CA,PIK3R1,PLCG1,RAPGEF1,STAT3	
Regulation of TP53 Activity through Acetylation	1.44E00	1.33E-01	2.000	AKT3,CHD4,KAT6A,PIP4K2A	
Mitochondrial Dysfunction	1.43E00	6.4E-02	0.000	APP,CACNA1A,CREB3L2,CREBBP,CYB5B,FBXW7,GPD2,ITPR1,ITPR2,ITPR3,MAOA,MAP2K4,NRF1,OPA1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,PPP3CC,PRKN,SIRT1	
Hepatic Fibrosis / Hepatic Stellate Cell Activation	1.43E00	7.22E-02	NaN	ECE1,FLT1,FLT4,FN1,IGF1R,MYH10,MYH9,MYO10,MYO18A,PDGFD,TGFB2,TGFBR2,VEGFC,VEGFD	
PI3K Cascade	1.42E00	1.14E-01	2.236	FRS2,GAB1,GAB2,PIK3CA,PIK3R1	
Metabolism of water-soluble vitamins and cofactors	1.42E00	1.02E-01	2.449	ACACA,ACACB,MTR,PCCA,PDXK,TPK1	
Unfolded Protein Response (UPR)	1.41E00	1.67E-01	NaN	ATF6,CREB3L2,MBTPS2	
Role of Osteoclasts in Rheumatoid Arthritis Signaling Pathway	1.4E00	6.49E-02	3.130	AKT3,BRAF,CBL,CREB3L2,CREBBP,CTNNA1,FOXO1,FOXO3,MAP2K4,MAP2K5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPP3CA,PPP3CC,SOS2,TAB2,XIAP	
L1CAM interactions	1.4E00	8E-02	3.162	CLTC,DLG1,DNM3,ITGA1,NRP1,RANBP9,RPS6KA3,RPS6KA5,SPTAN1,SPTBN1	
GADD45 Signaling	1.39E00	1E-01	2.449	ACVR1,FOXO3,MAP2K4,POU2F1,TGFB2,TGFBR2	
Degradation of beta-catenin by the destruction complex	1.38E00	8.7E-02	1.342	APC,BTRC,LEF1,PPP2R5E,PSME4,TCF4,TCF7L1,TCF7L2	
TCR signaling	1.38E00	7.94E-02	3.162	BTRC,ENAH,EVL,PIK3CA,PIK3R1,PLCG1,PSME4,PTEN,PTPRJ,TAB2	
Thiamin Salvage III	1.37E00	1E00	NaN	TPK1	
DNA Damage Reversal	1.37E00	2.5E-01	NaN	ASCC3,FTO	
IL-12 Signaling and Production in Macrophages	1.37E00	6.81E-02	-0.500	AKT3,NCOA1,NFAT5,PIAS2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,POU2F1,PRKCE,PRKCH,PRKCI,PRKD3,SIRT1,STAT3,TGFB2	
Semaphorin Signaling in Neurons	1.36E00	9.84E-02	NaN	ARHGEF12,NRP1,PLXNA2,PTK2,ROCK1,SEMA7A	
Apelin Pancreas Signaling Pathway	1.35E00	1.09E-01	1.342	MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3	
RHO GTPases activate CIT	1.35E00	1.58E-01	NaN	MYH10,MYH9,PPP1R12A	
Antiproliferative Role of Somatostatin Receptor 2	1.35E00	9.09E-02	2.236	BRAF,GNG12,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SMARCC2	
NRF2-mediated Oxidative Stress Response	1.34E00	6.75E-02	3.000	ABCC4,CREBBP,DNAJC1,DNAJC13,DNAJC5,MAP2K4,MAP2K5,MAP3K1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCE,PRKCH,PRKCI,PRKD3	
IL-2 Signaling	1.33E00	9.68E-02	2.449	AKT3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SOS2	
Interleukin-1 family signaling	1.32E00	7.75E-02	3.162	BTRC,IRAK3,MAP2K4,MAP3K3,PELI1,PSME4,PTPN14,PTPN4,STAT3,TAB2	
IL-6 Signaling	1.32E00	7.75E-02	3.162	ABCB1,AKT3,MAP2K4,MAP4K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SOS2,STAT3	
Breast Cancer Regulation by Stathmin1	1.32E00	5.72E-02	4.596	ADGRF5,ANKHD1/ANKHD1-EIF4EBP3,ARHGEF10,ARHGEF11,ARHGEF12,ARHGEF3,ARHGEF9,CALCRL,CDK6,CREB3L2,CREBBP,FZD6,GNAQ,GNG12,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PPM1L,PPP1R12A,PPP2R5E,PRKCE,PRKCH,PRKCI,PRKD3,RB1CC1,RPS6KA3,SOS2,STAT3,TGFB2,VEGFC,VEGFD	
CDX Gastrointestinal Cancer Signaling Pathway	1.31E00	6.93E-02	-2.138	AKT3,BRAF,FZD6,LEF1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTEN,STAT3,TCF4,TCF7L1,TCF7L2,TGFB2	
MAPK targets/ Nuclear events mediated by MAP kinases	1.3E00	1.21E-01	2.000	MAP2K4,MEF2C,RPS6KA3,RPS6KA5	
Regulation of eIF4 and p70S6K Signaling	1.3E00	7.07E-02	1.890	AGO1,AGO3,AKT3,EIF4G1,EIF4G3,ITGA1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP2R5E,SOS2	
Death Receptor Signaling	1.29E00	8.33E-02	2.121	CRADD,MAP2K4,MAP4K4,PARP14,ROCK1,SPTAN1,TNKS,XIAP	
Acute Phase Response Signaling	1.28E00	7.03E-02	1.732	AKT3,CP,FN1,MAP2K4,MAP3K1,OSMR,PIK3CA,PIK3R1,PIK3R3,SOS2,STAT3,TCF4,VWF	
Abacavir ADME	1.28E00	2.22E-01	NaN	ABCB1,NT5C2	
Sphingosine and Sphingosine-1-phosphate Metabolism	1.28E00	2.22E-01	NaN	ACER2,SGPP2	
Transcriptional Regulation by E2F6	1.26E00	1.18E-01	NaN	CBX5,EHMT1,MGA,PHC3	
Response to elevated platelet cytosolic Ca2+	1.26E00	7.58E-02	3.162	ABCC4,APP,FN1,LHFPL2,PHACTR2,TGFB2,TLN1,VEGFC,VEGFD,VWF	
MicroRNA Biogenesis Signaling Pathway	1.25E00	6.95E-02	2.496	AGO1,AGO3,AKT3,CSDE1,Fus,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SMAD5,TGFB2,XRN1,YAP1	
Regulation of Actin-based Motility by Rho	1.25E00	7.83E-02	0.707	ITGA1,MPRIP,PI4KA,PIKFYVE,PIP4K2A,PPP1R12A,Ppp1r12b,ROCK1,WIPF1	
Activation of anterior HOX genes in hindbrain during early embryogenesis	1.25E00	8.64E-02	2.646	CREBBP,KDM6A,KMT2C,KMT2D,NCOR1,PBX1,PIAS2	
NAD Signaling Pathway	1.24E00	7.28E-02	3.317	AKT3,HMGCS2,PARP14,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SIRT1,SLC12A8,TGFB2,TNKS	
Bladder Cancer Signaling	1.23E00	7.76E-02	NaN	HDAC4,HDAC7,HDAC8,RB1,RBL2,RPS6KA5,SIN3A,VEGFC,VEGFD	
Signaling by NOTCH3	1.22E00	1E-01	2.236	CREBBP,KAT2B,MAML3,MIB1,PBX1	
CREB Signaling in Neurons	1.21E00	5.6E-02	5.477	ADCY9,ADGRF5,AKT3,BMPR2,CACNA1A,CALCRL,CREB3L2,CREBBP,FLT1,FLT4,FZD6,GHR,GNAQ,GNG12,IGF1R,INSR,ITPR1,ITPR2,ITPR3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,SOS2,TGFB2,TGFBR2,TGFBR3	
Th1 and Th2 Activation Pathway	1.2E00	6.98E-02	NaN	ACVR1,BMPR2,CHD4,HLA-A,NOTCH4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,STAT3,TGFBR2,TGFBR3	
SNARE Signaling Pathway	1.19E00	7.35E-02	3.162	ADCY9,DNAJC5,MYH10,MYH9,MYO10,MYO18A,STXBP5,STXBP6,SYT7,VTI1A	
Cell Cycle: G2/M DNA Damage Checkpoint Regulation	1.19E00	9.8E-02	-0.447	BTRC,HIPK2,KAT2B,TOP2B,TRIP12	
Superpathway of D-myo-inositol (1,4,5)-trisphosphate Metabolism	1.19E00	1.36E-01	NaN	INPP5F,ITPKB,PTEN	
Mitotic Roles of Polo-Like Kinase	1.19E00	8.96E-02	NaN	ANAPC1,PPM1L,PPP2R5E,RAD21,SLK,SMC1A	
mRNA Editing	1.19E00	2E-01	NaN	ADARB1,APOBEC3B	
MSP-RON Signaling in Macrophages Pathway	1.18E00	7.56E-02	2.646	CREB3L2,CREBBP,GAB2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SOS2,STAT3	
Xenobiotic Metabolism CAR Signaling Pathway	1.15E00	6.7E-02	0.277	ABCB1,CHST11,CREBBP,MAP2K4,MAP2K5,NCOA1,NDST1,PPM1L,PPP2R5E,PRKCE,PRKCH,PRKCI,PRKD3	
SPINK1 General Cancer Pathway	1.14E00	8.7E-02	2.449	AKT3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,STAT3	
NoRC negatively regulates rRNA expression	1.12E00	1.05E-01	2.000	ARID4B,BAZ2A,SAP130,SIN3A	
IL-22 Signaling	1.1E00	1.25E-01	NaN	AKT3,MAP2K4,STAT3	
ISG15 antiviral mechanism	1.09E00	8.45E-02	2.449	ARIH1,EIF4G1,EIF4G3,FLNB,PLCG1,TRIM25	
Extracellular matrix organization	1.09E00	7.55E-02	2.828	APP,FN1,ITGA1,LAMA3,LAMA4,LAMB2,SH3PXD2A,TGFB2	
Cardiac Î²-adrenergic Signaling	1.09E00	6.67E-02	1.134	ADCY9,AKAP10,AKAP13,CACNA1A,GNAQ,GNG12,PDE5A,PDE7B,PDE8A,PPM1L,PPP1R12A,PPP2R5E	
S100 Family Signaling Pathway	1.08E00	5.31E-02	5.466	ABCB1,ADGRF5,AHNAK,AKT3,APP,ARNT,BRAF,CACNA1A,CALCRL,CREB3L2,CREBBP,FZD6,IRAK3,ITPR1,ITPR2,ITPR3,LEF1,MAP2K4,MAP2K5,MYH9,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLA2G4A,PLCB1,PLCB4,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,ROCK1,SMAD5,STAT3,TCF4,TCF7L1,TCF7L2,TGFB2,VEGFC,VEGFD	
Meiotic synapsis	1.08E00	9.09E-02	2.236	RAD21,SMC1A,STAG1,SYNE1,SYNE2	
All-trans-decaprenyl Diphosphate Biosynthesis	1.08E00	5E-01	NaN	PDSS2	
Glycerol-3-phosphate Shuttle	1.08E00	5E-01	NaN	GPD2	
GDP-L-fucose Biosynthesis I (from GDP-D-mannose)	1.08E00	5E-01	NaN	GMDS	
Basal Cell Carcinoma Signaling	1.07E00	8.33E-02	2.449	APC,FZD6,LEF1,TCF4,TCF7L1,TCF7L2	
Inhibition of ARE-Mediated mRNA Degradation Pathway	1.06E00	6.75E-02	-1.508	AGO1,AGO3,AKT3,CNOT1,CNOT4,DDX6,PAPOLA,PPM1L,PPP2R5E,PSME4,XRN1	
Neutrophil Extracellular Trap Signaling Pathway	1.06E00	5.75E-02	4.796	AKT3,DOCK1,ITPR1,ITPR2,ITPR3,MAP2K4,MAP2K5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLA2G4A,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,STIM1,YES1	
MyD88 cascade initiated on plasma membrane	1.06E00	1.2E-01	NaN	MAP3K1,PELI1,TAB2	
ISGylation Signaling Pathway	1.05E00	7.41E-02	0.707	ARIH1,CREBBP,FLNB,MAP2K4,NFAT5,PRKN,TRIM25,XIAP	
GP1b-IX-V activation signalling	1.05E00	1.67E-01	NaN	PIK3R1,VWF	
Ion channel transport	1.05E00	6.56E-02	3.464	ANO6,ATP10A,ATP11A,ATP11C,ATP2B4,ATP6V0A1,ATP8A1,ATP9B,NEDD4L,TRPM7,WNK1,WWP1	
Factors involved in megakaryocyte development and platelet production	1.04E00	7.69E-02	2.646	AKAP10,DOCK1,DOCK4,DOCK6,DOCK9,PHF21A,SIN3A	
BMP signaling pathway	1.04E00	7.69E-02	1.633	ACVR1,BMPR2,CREBBP,MAP2K4,SMAD5,SMURF1,XIAP	
Role of IL-17A in Arthritis	1.03E00	8.77E-02	NaN	MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3	
IL-27 Signaling Pathway	1.02E00	7.03E-02	2.333	AKT3,ENTPD1,HLA-A,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RORA,STAT3	
Cell junction organization	1.02E00	7.61E-02	2.646	AFDN,CADM1,CDH13,CTNNA1,LAMA3,PARD3,PRKCI	
HMGB1 Signaling	1E00	6.59E-02	3.317	AKT3,KAT2B,KAT6A,Kat6b,MAP2K4,MAP2K5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,TGFB2	
Fc epsilon receptor (FCERI) signaling	9.99E-01	6.31E-02	3.162	BTRC,GAB2,ITPR1,ITPR2,ITPR3,MAP2K4,MAP3K1,PIK3CA,PIK3R1,PLCG1,PPP3CA,PSME4,TAB2	
MyD88:MAL(TIRAP) cascade initiated on plasma membrane	9.94E-01	9.52E-02	2.000	IRAK3,MAP3K1,PELI1,TAB2	
Cardiac conduction	9.93E-01	6.92E-02	2.449	ATP2B4,HIPK1,HIPK2,ITPR1,ITPR2,ITPR3,KAT2B,STIM1,WWTR1	
Neddylation	9.91E-01	6.1E-02	3.357	BTRC,COP1,DCAF5,DCAF6,EPAS1,FBXL20,FBXL7,FBXO11,FBXW7,KLHL2,KLHL3,LMO7,PSME4,PUM2,TULP4	
Azathioprine ADME	9.88E-01	1.54E-01	NaN	ABCC4,XDH	
Guanosine Nucleotides Degradation III	9.88E-01	1.54E-01	NaN	NT5C2,XDH	
Signaling by Insulin receptor	9.66E-01	9.3E-02	2.000	ATP6V0A1,INSR,PIK3CA,PIK3R1	
EIF2 Signaling	9.49E-01	6.09E-02	3.162	AGO1,AGO3,AKT3,EIF4G1,EIF4G3,IGF1R,INSR,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RPL31,SOS2,XIAP	
IL-1 Signaling	9.46E-01	7.29E-02	2.000	ADCY9,GNAQ,GNG12,IRAK3,MAP2K4,MAP3K1,TAB2	
RHO GTPases activate PKNs	9.44E-01	1.07E-01	NaN	MYH10,MYH9,PPP1R12A	
BER (Base Excision Repair) Pathway	9.39E-01	9.09E-02	1.000	HUWE1,MAP2K4,MAP2K5,NF1	
Sleep NREM Signaling Pathway	9.36E-01	6.96E-02	-2.121	ADCY9,BRAF,CREB3L2,CREBBP,HDAC4,MAP2K4,MAP2K5,SIK3	
Aspirin ADME	9.33E-01	1.43E-01	NaN	SLC16A1,SLCO2B1	
Formation of axial mesoderm	9.33E-01	1.43E-01	NaN	LEF1,YAP1	
Urate Biosynthesis/Inosine 5'-phosphate Degradation	9.33E-01	1.43E-01	NaN	NT5C2,XDH	
IL-10 Signaling	9.21E-01	6.49E-02	1.265	AKT3,BCL2L1,CREB3L2,CREBBP,HLA-A,MAP2K4,MAP4K4,PBX1,SIRT1,STAT3	
G alpha (q) signalling events	9.13E-01	6.32E-02	3.317	APP,GNAQ,GNG12,GRK5,KALRN,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,TRIO	
Role of JAK2 in Hormone-like Cytokine Signaling	9.13E-01	8.06E-02	2.236	BCL2L1,GHR,STAT3,VEGFC,VEGFD	
Xenobiotic Metabolism PXR Signaling Pathway	8.97E-01	6.15E-02	0.577	ABCB1,CHST11,CREBBP,MAOA,NCOA1,NCOR1,NDST1,PPP1R12A,PRKCE,PRKCH,PRKCI,PRKD3	
Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses	8.95E-01	6.41E-02	3.000	MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCE,PRKCH,PRKCI,PRKD3,TGFB2	
Glycerophospholipid biosynthesis	8.95E-01	7.07E-02	2.646	CDS2,ETNK1,GPCPD1,OSBPL8,PLA2G4A,PLD1,SLC44A1	
Role of OCT4 in Mammalian Embryonic Stem Cell Pluripotency	8.86E-01	8.7E-02	NaN	JARID2,PHC3,RB1,TASOR	
Regulation of cholesterol biosynthesis by SREBP (SREBF)	8.82E-01	1.33E-01	NaN	MBTPS2,SEC24B	
Platelet Adhesion to exposed collagen	8.82E-01	1.33E-01	NaN	ITGA1,VWF	
Activation of kainate receptors upon glutamate binding	8.77E-01	1E-01	NaN	DLG1,GNG12,PLCB1	
Nucleotide catabolism	8.77E-01	1E-01	NaN	ENTPD1,NT5C2,XDH	
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes	8.77E-01	1E-01	NaN	FOXO1,FOXO3,SIN3A	
Role of IL-17F in Allergic Inflammatory Airway Diseases	8.62E-01	8.51E-02	NaN	CREB3L2,CREBBP,RPS6KA3,RPS6KA5	
Signaling by NOTCH4	8.53E-01	7.23E-02	2.449	CREBBP,FBXW7,FLT4,KAT2B,MAML3,NOTCH4	
Toll-like Receptor Cascades	8.46E-01	9.68E-02	NaN	DNM3,EEA1,PTPN4	
MyD88 dependent cascade initiated on endosome	8.46E-01	9.68E-02	NaN	MAP3K1,PELI1,TAB2	
G alpha (z) signalling events	8.38E-01	8.33E-02	2.000	ADCY9,GNG12,PRKCE,PRKCH	
nNOS Signaling in Skeletal Muscle Cells	8.38E-01	8.33E-02	NaN	CACNA1A,ITPR1,ITPR2,ITPR3	
Apelin Muscle Signaling Pathway	8.38E-01	8.33E-02	NaN	AKT3,GNAQ,GNG12,NRF1	
Role of Chondrocytes in Rheumatoid Arthritis Signaling Pathway	8.37E-01	6.38E-02	2.333	FN1,FOXO3,MAP2K4,PPP3CA,PPP3CC,RPTOR,STAT3,VEGFC,VEGFD	
Prolactin receptor signaling	8.36E-01	1.25E-01	NaN	BTRC,GHR	
Adenosine Nucleotides Degradation II	8.36E-01	1.25E-01	NaN	NT5C2,XDH	
Role of PI3K/AKT Signaling in the Pathogenesis of Influenza	8.3E-01	7.58E-02	2.236	AKT3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3	
G-protein beta:gamma signalling	8.16E-01	9.38E-02	NaN	AKT3,GNG12,PLCB1	
TNFR2 Signaling	8.16E-01	9.38E-02	NaN	MAP2K4,MAP3K1,XIAP	
TP53 Regulates Transcription of Cell Cycle Genes	8.15E-01	8.16E-02	2.000	CNOT1,CNOT4,CNOT6L,RBL2	
Wax and plasmalogen biosynthesis	7.98E-01	2.5E-01	NaN	FAR2	
Methylmalonyl Pathway	7.98E-01	2.5E-01	NaN	PCCA	
Methionine Salvage II (Mammalian)	7.98E-01	2.5E-01	NaN	MTR	
Melatonin Degradation II	7.98E-01	2.5E-01	NaN	MAOA	
Oxidized GTP and dGTP Detoxification	7.98E-01	2.5E-01	NaN	DDX6	
1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian)	7.94E-01	1.18E-01	NaN	INPP5F,ITPKB	
Signal amplification	7.88E-01	9.09E-02	NaN	GNAQ,GNG12,PLA2G4A	
C-type lectin receptors (CLRs)	7.86E-01	6.21E-02	3.000	BTRC,CREBBP,ITPR1,ITPR2,ITPR3,PPP3CA,PSME4,RPS6KA5,TAB2	
Regulation of the Epithelial Mesenchymal Transition in Development Pathway	7.85E-01	6.9E-02	NaN	APC,FZD6,LEF1,TCF4,TCF7L1,TCF7L2	
GÎ±s Signaling	7.78E-01	6.35E-02	1.342	ADCY9,ADD1,BRAF,CREB3L2,CREBBP,GNAQ,GNG12,RAPGEF2	
Role of JAK1 and JAK3 in Î³c Cytokine Signaling	7.74E-01	7.25E-02	NaN	PIK3C2A,PIK3CA,PIK3R1,PIK3R3,STAT3	
Phospholipases	7.74E-01	7.25E-02	2.236	PLA2G4A,PLCB1,PLCB4,PLCG1,PLD1	
PPAR Signaling	7.71E-01	6.54E-02	-1.134	CREBBP,INSR,MAP4K4,NCOA1,NCOR1,PDGFD,SOS2	
TNFR1 Signaling	7.7E-01	7.84E-02	1.000	CRADD,MAP2K4,MAP3K1,XIAP	
Gap junction trafficking and regulation	7.61E-01	8.82E-02	NaN	CLTC,MYO6,TJP1	
Inhibition of Angiogenesis by TSP1	7.61E-01	8.82E-02	NaN	AKT3,MAP2K4,TGFBR2	
Regulation of Cellular Mechanics by Calpain Protease	7.38E-01	6.67E-02	NaN	CDK6,ITGA1,PTK2,RB1,TLN1,TLN2	
GPVI-mediated activation cascade	7.35E-01	8.57E-02	NaN	PIK3CA,PIK3R1,PIK3R3	
Macrophage Alternative Activation Signaling Pathway	7.33E-01	5.79E-02	3.317	CREB3L2,CREBBP,EPAS1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RPS6KA5,RPTOR,STAT3,TGFB2	
KEAP1-NFE2L2 pathway	7.23E-01	6.59E-02	2.449	AKT3,BTRC,CREBBP,FBXL17,PSME4,SESN1	
COPII-mediated vesicle transport	7.21E-01	6.94E-02	2.236	ANKRD28,ANKRD44,PPP6R3,SEC24B,TRAPPC9	
Purine Nucleotides Degradation II (Aerobic)	7.17E-01	1.05E-01	NaN	NT5C2,XDH	
Choline catabolism	7.1E-01	2E-01	NaN	SLC44A1	
Creatine-phosphate Biosynthesis	7.1E-01	2E-01	NaN	MAP4K4	
Myo-inositol Biosynthesis	7.1E-01	2E-01	NaN	INPP5F	
2-oxobutanoate Degradation I	7.1E-01	2E-01	NaN	PCCA	
Acetate Conversion to Acetyl-CoA	7.1E-01	2E-01	NaN	DIP2A	
RHO GTPases Activate WASPs and WAVEs	7.1E-01	8.33E-02	NaN	NCKAP1,PTK2,WIPF1	
Senescence-Associated Secretory Phenotype (SASP)	7.05E-01	6.85E-02	2.236	ANAPC1,CDK6,EHMT1,RPS6KA3,STAT3	
Regulation of RUNX2 expression and activity	7.05E-01	6.85E-02	2.236	FBXW7,HIVEP3,PSME4,SMURF1,WWP1	
Glioma Invasiveness Signaling	7.05E-01	6.85E-02	2.236	PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2	
E3 ubiquitin ligases ubiquitinate target proteins	6.9E-01	7.27E-02	2.000	CDC73,HLA-A,SHPRH,WAC	
SUMOylation of transcription factors	6.83E-01	1E-01	NaN	PIAS1,PIAS2	
Caveolar-mediated Endocytosis Signaling	6.73E-01	6.67E-02	NaN	FLNB,HLA-A,INSR,ITGA1,MAP3K2	
Necroptosis Signaling Pathway	6.72E-01	5.81E-02	3.000	MERTK,PELI1,PLA2G4A,PPP3CA,PPP3CC,RB1,RBL2,TAB2,TRPM7	
Cell Cycle Regulation by BTG Family Proteins	6.63E-01	7.89E-02	NaN	PPM1L,PPP2R5E,RB1	
Hypoxia Signaling in the Cardiovascular System	6.57E-01	6.58E-02	NaN	ARNT,BIRC6,CREB3L2,CREBBP,PTEN	
TNF signaling	6.54E-01	7.02E-02	2.000	OTUD7B,SPPL2A,TAB2,XIAP	
Endoplasmic Reticulum Stress Pathway	6.51E-01	9.52E-02	NaN	ATF6,MBTPS2	
MAP kinase activation	6.41E-01	7.69E-02	NaN	BTRC,MAP2K4,TAB2	
Regulation of TP53 Expression and Degradation	6.41E-01	7.69E-02	NaN	AKT3,MAPKAP1,RICTOR	
Superpathway of Methionine Degradation	6.41E-01	7.69E-02	NaN	EHMT1,MTR,PCCA	
Chondroitin and Dermatan Biosynthesis	6.4E-01	1.67E-01	NaN	CSGALNACT1	
Glycerol Degradation I	6.4E-01	1.67E-01	NaN	GPD2	
Role of CHK Proteins in Cell Cycle Checkpoint Control	6.36E-01	6.9E-02	NaN	PPM1L,PPP2R5E,TLK1,TLK2	
MSP-RON Signaling Pathway	6.36E-01	6.9E-02	NaN	PIK3C2A,PIK3CA,PIK3R1,PIK3R3	
Iron homeostasis signaling pathway	6.34E-01	5.8E-02	NaN	ARNT,ATP6V0A1,BMPR2,BTRC,CP,EPAS1,SMAD5,STAT3	
Aryl Hydrocarbon Receptor Signaling	6.31E-01	5.66E-02	-0.333	ARNT,CDK6,NCOA2,NFIA,RB1,RBL2,SMARCA4,TGFB2,TRIP11	
Toll-like Receptor Signaling	6.27E-01	6.41E-02	2.000	IRAK3,MAP2K4,MAP3K1,MAP4K4,TAB2	
Protein folding	6.26E-01	6.12E-02	2.449	FBXW7,GNAQ,GNG12,KIF13A,STAT3,TBCD	
DDX58/IFIH1-mediated induction of interferon-alpha/beta	6.13E-01	6.33E-02	2.236	APP,CREBBP,MAP3K1,RNF216,TRIM25	
Coronavirus Pathogenesis Pathway	6.03E-01	5.39E-02	-1.508	HDAC4,HDAC7,HDAC8,MAP2K4,PIKFYVE,RB1,RBL2,SIN3A,STAT3,TGFBR2,TRIM25	
Transport of vitamins, nucleosides, and related molecules	6E-01	7.32E-02	NaN	SLC16A2,SLCO1C1,SLCO2B1	
RNA Polymerase III Transcription	6E-01	7.32E-02	NaN	NFIA,POU2F1,SNAPC3	
Dopamine Receptor Signaling	5.99E-01	6.25E-02	NaN	ADCY9,MAOA,PPM1L,PPP1R12A,PPP2R5E	
Apelin Cardiac Fibroblast Signaling Pathway	5.94E-01	8.7E-02	NaN	AKT3,TGFB2	
NCAM signaling for neurite out-growth	5.87E-01	6.56E-02	2.000	PTK2,RPS6KA5,SPTAN1,SPTBN1	
Kinesins	5.87E-01	6.56E-02	2.000	KIF13B,KIF16B,KIF1B,KIF1C	
Th1 Pathway	5.84E-01	5.74E-02	2.646	HLA-A,NOTCH4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,STAT3	
IL-33 Signaling Pathway	5.84E-01	5.41E-02	3.162	AKT3,BCL2L1,CREB3L2,CREBBP,MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,STAT3	
Aryl hydrocarbon receptor signalling	5.82E-01	1.43E-01	NaN	ARNT	
STAT5 Activation	5.82E-01	1.43E-01	NaN	GAB2	
Atorvastatin ADME	5.82E-01	1.43E-01	NaN	SLCO2B1	
Ceramide Degradation	5.82E-01	1.43E-01	NaN	ACER2	
Glycogen Biosynthesis II (from UDP-D-Glucose)	5.82E-01	1.43E-01	NaN	GBE1	
DAP12 interactions	5.8E-01	7.14E-02	NaN	PIK3CA,PIK3R1,PLCG1	
April Mediated Signaling	5.8E-01	7.14E-02	NaN	MAP2K4,MAP3K1,NFAT5	
UFMylation Signaling Pathway	5.71E-01	6.45E-02	1.000	AKT3,EIF4G1,EIF4G3,NCOA1	
Glycogen metabolism	5.67E-01	8.33E-02	NaN	GBE1,PHKB	
Growth hormone receptor signaling	5.67E-01	8.33E-02	NaN	GHR,STAT3	
IL-17 Signaling	5.66E-01	5.35E-02	3.162	AKT3,MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,TAB2,TGFB2,VEGFC,VEGFD	
Wound Healing Signaling Pathway	5.63E-01	5.16E-02	3.051	ACVR1,BMPR2,FN1,LAMA3,MAP2K4,MAP2K5,PDGFD,SOS2,TGFB2,TGFBR2,TGFBR3,VEGFC,VEGFD	
B Cell Activating Factor Signaling	5.61E-01	6.98E-02	NaN	MAP2K4,MAP3K1,NFAT5	
Oncostatin M Signaling	5.61E-01	6.98E-02	NaN	EPAS1,OSMR,STAT3	
Transport of bile salts and organic acids, metal ions and amine compounds	5.59E-01	6.02E-02	2.236	CP,SLC16A1,SLC30A1,SLC39A10,SLC44A1	
Heparan Sulfate Biosynthesis (Late Stages)	5.59E-01	6.02E-02	2.236	CHST11,EXT1,EXTL3,LIPE,NDST1	
Serine biosynthesis	5.33E-01	1.25E-01	NaN	SERINC3	
NFE2L2 regulates pentose phosphate pathway genes	5.33E-01	1.25E-01	NaN	CREBBP	
Inositol Pyrophosphates Biosynthesis	5.33E-01	1.25E-01	NaN	IP6K1	
Sphingomyelin Metabolism	5.33E-01	1.25E-01	NaN	SGMS1	
Macroautophagy	5.27E-01	6.15E-02	2.000	AMBRA1,RB1CC1,RPTOR,UVRAG	
GPER1 signaling	5.26E-01	6.67E-02	NaN	ADCY9,FN1,GNG12	
cAMP-mediated signaling	5.21E-01	5.08E-02	3.000	ADCY9,AKAP10,AKAP13,BRAF,CREB3L2,CREBBP,PDE5A,PDE7B,PDE8A,PPP3CA,PPP3CC,STAT3	
Cargo recognition for clathrin-mediated endocytosis	5.21E-01	5.61E-02	2.449	AAK1,CBL,CLTC,FCHO2,ITSN2,PICALM	
Sphingolipid metabolism	5.1E-01	5.75E-02	2.236	ESYT2,PPM1L,PRKD3,SGMS1,SGPP2	
Xenobiotic Metabolism AHR Signaling Pathway	5.1E-01	5.75E-02	1.342	ARNT,CREBBP,HDAC4,NCOA1,NCOA2	
SUMOylation of RNA binding proteins	5.09E-01	6.52E-02	NaN	HNRNPC,PHC3,SCMH1	
tRNA Splicing	5.09E-01	6.52E-02	NaN	PDE5A,PDE7B,PDE8A	
DNA damage-induced 14-3-3Ï Signaling	5.09E-01	6.52E-02	NaN	AKT3,BCL2L1,COP1	
Regulation of mitotic cell cycle	4.98E-01	5.68E-02	2.236	ANAPC1,BTRC,CDC14A,PSME4,RB1	
Ferroptosis Signaling Pathway	4.94E-01	5.34E-02	1.134	ACACA,BRAF,RB1,RBL2,STAT3,WWTR1,YAP1	
Butyrophilin (BTN) family interactions	4.91E-01	1.11E-01	NaN	XDH	
Interleukin-9 signaling	4.91E-01	1.11E-01	NaN	STAT3	
Prednisone ADME	4.91E-01	1.11E-01	NaN	ABCB1	
Phosphatidylethanolamine Biosynthesis II	4.91E-01	1.11E-01	NaN	ETNK1	
Salvage Pathways of Pyrimidine Deoxyribonucleotides	4.91E-01	1.11E-01	NaN	APOBEC3B	
Folate Transformations I	4.91E-01	1.11E-01	NaN	MTR	
Remodeling of Epithelial Adherens Junctions	4.87E-01	5.88E-02	NaN	APC,CTNNA1,DNM3,EXOC2	
GABA Receptor Signaling	4.84E-01	5.3E-02	NaN	ADCY9,CACNA1A,GNAQ,GNG12,ITPR1,ITPR2,ITPR3	
XBP1(S) activates chaperone genes	4.77E-01	6.25E-02	NaN	ADD1,EXTL3,TLN1	
MTOR signalling	4.76E-01	7.14E-02	NaN	EIF4G1,RPTOR	
Activated PKN1 stimulates transcription of AR regulated genes KLK2 and KLK3	4.76E-01	7.14E-02	NaN	KDM4C,NCOA2	
CDP-diacylglycerol Biosynthesis I	4.76E-01	7.14E-02	NaN	CDS2,GPD2	
Heparan Sulfate Biosynthesis	4.76E-01	5.56E-02	2.236	CHST11,EXT1,EXTL3,LIPE,NDST1	
Unfolded protein response	4.76E-01	5.56E-02	NaN	ATF6,DNAJC1,DNAJC13,DNAJC5,MBTPS2	
Sensory processing of sound by inner hair cells of the cochlea	4.74E-01	5.8E-02	2.000	DNAJC5,MYH9,SPTAN1,SPTBN1	
Mitotic G2-G2/M phases	4.72E-01	5.03E-02	3.162	BTRC,CKAP5,CLASP1,DYNC1H1,FBXL7,LIN52,PCM1,PPP1R12A,PSME4,SDCCAG8	
Neurotransmitter clearance	4.54E-01	1E-01	NaN	MAOA	
ATF6 (ATF6-alpha) activates chaperone genes	4.54E-01	1E-01	NaN	ATF6	
Ketone body metabolism	4.54E-01	1E-01	NaN	HMGCS2	
Calcium Transport I	4.54E-01	1E-01	NaN	ATP2B4	
Antioxidant Action of Vitamin C	4.51E-01	5.26E-02	-2.449	MAP2K4,PLA2G4A,PLCB1,PLCB4,PLCG1,PLD1	
MYC Mediated Apoptosis Signaling	4.48E-01	6E-02	NaN	BCL2L1,CRADD,CREBBP	
Actin Nucleation by ARP-WASP Complex	4.44E-01	5.38E-02	NaN	ITGA1,PPP1R12A,ROCK1,SOS2,WIPF1	
CDK5 Signaling	4.41E-01	5.22E-02	1.000	ADCY9,CACNA1A,LAMA3,PPM1L,PPP1R12A,PPP2R5E	
Signaling by CSF3 (G-CSF)	4.37E-01	6.67E-02	NaN	GAB2,STAT3	
Phosphatidylglycerol Biosynthesis II (Non-plastidic)	4.37E-01	6.67E-02	NaN	CDS2,GPD2	
Transcriptional regulation of granulopoiesis	4.34E-01	5.88E-02	NaN	FLI1,LEF1,STAT3	
Amyloid Processing	4.34E-01	5.88E-02	NaN	AKT3,APP,PRKCE	
Cell Cycle Checkpoints	4.32E-01	4.78E-02	3.606	ANAPC1,BABAM2,CENPC,CKAP5,CLASP1,CLASP2,COP1,DYNC1H1,HERC2,MAD1L1,PPP2R5E,PSME4,TAOK1	
Amyloid fiber formation	4.26E-01	5.48E-02	2.000	APP,PRKN,TSPAN5,USP9X	
Neurotransmitter receptors and postsynaptic signal transmission	4.21E-01	9.09E-02	NaN	NBEA	
Signaling by Leptin	4.21E-01	9.09E-02	NaN	STAT3	
Processing and activation of SUMO	4.21E-01	9.09E-02	NaN	SENP2	
Aspartate and asparagine metabolism	4.21E-01	9.09E-02	NaN	SLC25A12	
Alpha-protein kinase 1 signaling pathway	4.21E-01	9.09E-02	NaN	TAB2	
Pexophagy	4.21E-01	9.09E-02	NaN	EPAS1	
Ketogenesis	4.21E-01	9.09E-02	NaN	HMGCS2	
Bile acid and bile salt metabolism	4.19E-01	6.45E-02	NaN	NCOA1,NCOA2	
Chondroitin Sulfate Biosynthesis (Late Stages)	4.07E-01	5.66E-02	NaN	CHST11,CSGALNACT1,NDST1	
Cellular response to hypoxia	4.04E-01	5.33E-02	2.000	ARNT,CREBBP,EPAS1,PSME4	
Glutamate binding, activation of AMPA receptors and synaptic plasticity	4.02E-01	6.25E-02	NaN	DLG1,MYO6	
Thrombin signalling through proteinase activated receptors (PARs)	4.02E-01	6.25E-02	NaN	GNAQ,GNG12	
Presynaptic depolarization and calcium channel opening	3.92E-01	8.33E-02	NaN	CACNA1A	
Cell surface interactions at the vascular wall	3.92E-01	4.74E-02	3.162	FN1,GLG1,GRB14,MERTK,PIK3CA,PIK3R1,PLCG1,SLC16A1,TEK,YES1	
Sensory processing of sound by outer hair cells of the cochlea	3.82E-01	5.45E-02	NaN	MYH9,SPTAN1,SPTBN1	
Signaling by NOTCH2	3.71E-01	5.88E-02	NaN	MAML3,MIB1	
Triglyceride metabolism	3.71E-01	5.88E-02	NaN	GPD2,LIPE	
NLR signaling pathways	3.71E-01	5.36E-02	NaN	APP,BCL2L1,TAB2	
Folate Signaling Pathway	3.71E-01	5.36E-02	NaN	MTR,OGT,STAT3	
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	3.66E-01	7.69E-02	NaN	STAT3	
Platelet Aggregation (Plug Formation)	3.66E-01	7.69E-02	NaN	VWF	
Advanced glycosylation endproduct receptor signaling	3.66E-01	7.69E-02	NaN	APP	
Cleavage and Polyadenylation of Pre-mRNA	3.66E-01	7.69E-02	NaN	PAPOLA	
Role of MAPK Signaling in Inhibiting the Pathogenesis of Influenza	3.64E-01	5.06E-02	2.000	BRAF,MAP2K4,PLA2G4A,RPS6KA3	
Signaling by the B Cell Receptor (BCR)	3.63E-01	4.71E-02	2.236	BTRC,ITPR1,ITPR2,ITPR3,PIK3R1,PPP3CA,PSME4,STIM1	
Phase I - Functionalization of compounds	3.6E-01	4.9E-02	2.236	ARNT,CYB5B,MAOA,NCOA1,NCOA2	
COPI-mediated anterograde transport	3.6E-01	4.9E-02	2.236	COG5,DYNC1H1,GOLGB1,SPTAN1,SPTBN1	
Oxytocin in Spinal Neurons Signaling Pathway	3.56E-01	5.71E-02	NaN	PRKG1,SMARCC2	
PRC2 methylates histones and DNA	3.56E-01	5.71E-02	NaN	DNMT3A,JARID2	
Mitotic Prophase	3.52E-01	4.85E-02	2.236	LEMD3,MCPH1,NEK7,NEK9,RB1	
Triacylglycerol Degradation	3.48E-01	5.17E-02	NaN	ABHD2,LIPE,NDST1	
Regulation of TP53 Activity through Association with Co-factors	3.42E-01	7.14E-02	NaN	AKT3	
DNA Double-Strand Break Repair by Homologous Recombination	3.42E-01	7.14E-02	NaN	ATRX	
Mevalonate Pathway I	3.42E-01	7.14E-02	NaN	HMGCS2	
Phenylalanine Degradation IV (Mammalian, via Side Chain)	3.42E-01	7.14E-02	NaN	MAOA	
Colanic Acid Building Blocks Biosynthesis	3.42E-01	7.14E-02	NaN	GMDS	
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	3.42E-01	5.56E-02	NaN	CREBBP,WWOX	
DNA Double Strand Break Response	3.38E-01	5.08E-02	NaN	BABAM2,BAZ1B,HERC2	
RNA polymerase II transcribes snRNA genes	3.28E-01	4.82E-02	2.000	INTS9,POU2F1,RPRD2,SNAPC3	
GABA receptor activation	3.27E-01	5E-02	NaN	ADCY9,ARHGEF9,GNG12	
PCP (Planar Cell Polarity) Pathway	3.27E-01	5E-02	NaN	FZD6,MAP2K4,ROCK1	
Telomere Extension by Telomerase	3.2E-01	6.67E-02	NaN	TNKS	
Choline Biosynthesis III	3.2E-01	6.67E-02	NaN	PLD1	
Chondroitin Sulfate Biosynthesis	3.17E-01	4.92E-02	NaN	CHST11,CSGALNACT1,NDST1	
Mitotic G1 phase and G1/S transition	3.16E-01	4.58E-02	1.342	AKT3,CDK6,DYRK1A,LIN52,RB1,RBL2	
SUMOylation of ubiquitinylation proteins	3.16E-01	5.26E-02	NaN	PIAS1,PIAS2	
Notch Signaling	3.16E-01	5.26E-02	NaN	MAML3,NOTCH4	
NGF-stimulated transcription	3.04E-01	5.13E-02	NaN	CHD4,TCF12	
Hedgehog 'on' state	3.03E-01	4.65E-02	2.000	CDC73,PSME4,SMURF1,SMURF2	
Signal regulatory protein family interactions	3.01E-01	6.25E-02	NaN	PTK2	
Rap1 signalling	3.01E-01	6.25E-02	NaN	PRKG1	
D-myo-inositol (1,4,5)-trisphosphate Degradation	3.01E-01	6.25E-02	NaN	INPP5F	
Parkinson's Signaling	3.01E-01	6.25E-02	NaN	PRKN	
Dermatan Sulfate Biosynthesis	2.98E-01	4.76E-02	NaN	CHST11,CSGALNACT1,NDST1	
O-linked glycosylation	2.92E-01	4.5E-02	2.236	ADAMTS9,GALNT15,GALNT18,LARGE1,ST6GALNAC3	
Sleep REM Signaling Pathway	2.92E-01	4.5E-02	1.342	CREB3L2,CREBBP,RPS6KA3,RPS6KA5,TGFB2	
Neurotransmitter release cycle	2.92E-01	5E-02	NaN	MAOA,UNC13B	
Pyrimidine Ribonucleotides Interconversion	2.92E-01	5E-02	NaN	DDX3X,ENTPD1	
Germ layer formation at gastrulation	2.83E-01	5.88E-02	NaN	LEF1	
Induction of Apoptosis by HIV1	2.8E-01	4.62E-02	NaN	BCL2L1,MAP2K4,XIAP	
Role of MAPK Signaling in Promoting the Pathogenesis of Influenza	2.73E-01	4.39E-02	2.236	ATP6V0A1,BRAF,MAP2K4,PLA2G4A,RPS6KA3	
Degradation of the extracellular matrix	2.72E-01	4.55E-02	NaN	ADAMTS9,FN1,LAMA3	
Thyroid Hormone Metabolism II (via Conjugation and/or Degradation)	2.7E-01	4.76E-02	NaN	CSGALNACT1,LARGE1	
GABAergic Receptor Signaling Pathway (Enhanced)	2.67E-01	4.32E-02	-1.633	ADCY9,CACNA1A,GNG12,ITPR1,ITPR2,ITPR3	
Metabolism of Angiotensinogen to Angiotensins	2.66E-01	5.56E-02	NaN	AOPEP	
Gastrin-CREB signalling pathway via PKC and MAPK	2.66E-01	5.56E-02	NaN	RPS6KA3	
Formation of definitive endoderm	2.66E-01	5.56E-02	NaN	TCF7L2	
Superpathway of Geranylgeranyldiphosphate Biosynthesis I (via Mevalonate)	2.66E-01	5.56E-02	NaN	HMGCS2	
Crosstalk between Dendritic Cells and Natural Killer Cells	2.65E-01	4.4E-02	NaN	HLA-A,MICB,TLN1,TLN2	
Vasopressin regulates renal water homeostasis via Aquaporins	2.6E-01	4.65E-02	NaN	ADCY9,GNG12	
Assembly and cell surface presentation of NMDA receptors	2.6E-01	4.65E-02	NaN	DLG1,NBEA	
Aggrephagy	2.6E-01	4.65E-02	NaN	DYNC1H1,PRKN	
Pyrimidine Ribonucleotides De Novo Biosynthesis	2.6E-01	4.65E-02	NaN	DDX3X,ENTPD1	
Nonsense-Mediated Decay (NMD)	2.54E-01	4.27E-02	2.236	EIF4G1,RPL31,SMG1,SMG6,SMG7	
Regulation of TP53 Activity through Methylation	2.51E-01	5.26E-02	NaN	EHMT1	
GABA synthesis, release, reuptake and degradation	2.51E-01	5.26E-02	NaN	DNAJC5	
Metabolism of cofactors	2.51E-01	5.26E-02	NaN	PDSS2	
NFE2L2 regulating anti-oxidant/detoxification enzymes	2.51E-01	5.26E-02	NaN	CREBBP	
Mitochondrial L-carnitine Shuttle Pathway	2.51E-01	5.26E-02	NaN	CPT1A	
Elastic fibre formation	2.5E-01	4.55E-02	NaN	FN1,TGFB2	
TAK1-dependent IKK and NF-kappa-B activation	2.5E-01	4.55E-02	NaN	APP,TAB2	
Regulation of mRNA stability by proteins that bind AU-rich elements	2.5E-01	4.55E-02	NaN	EIF4G1,XRN1	
TP53 Regulates Transcription of Cell Death Genes	2.5E-01	4.55E-02	NaN	CRADD,CREBBP	
MIF Regulation of Innate Immunity	2.5E-01	4.55E-02	NaN	MAP2K4,PLA2G4A	
Agrin Interactions at Neuromuscular Junction	2.48E-01	4.35E-02	NaN	MAP2K4,PTK2,UTRN	
Superpathway of Melatonin Degradation	2.48E-01	4.35E-02	NaN	CSGALNACT1,LARGE1,MAOA	
Interferon gamma signaling	2.45E-01	4.26E-02	2.000	HLA-A,MID1,PIAS1,TRIM25	
TP53 Regulates Transcription of DNA Repair Genes	2.4E-01	4.29E-02	NaN	AP1G1,CDK12,CDK13	
Receptor-type tyrosine-protein phosphatases	2.37E-01	5E-02	NaN	PPFIBP1	
Interleukin-12 family signaling	2.37E-01	5E-02	NaN	STAT3	
Inflammasome pathway	2.37E-01	5E-02	NaN	NEK7	
Cytosolic sensors of pathogen-associated DNA	2.32E-01	4.35E-02	NaN	CREBBP,TRIM56	
Role of RIG1-like Receptors in Antiviral Innate Immunity	2.32E-01	4.35E-02	NaN	CREBBP,TRIM25	
Synaptic adhesion-like molecules	2.24E-01	4.76E-02	NaN	DLG1	
Digestion	2.24E-01	4.76E-02	NaN	PIR	
iNOS Signaling	2.23E-01	4.26E-02	NaN	CREBBP,IRAK3	
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane	2.11E-01	4.55E-02	NaN	APP	
Putrescine Degradation III	2.11E-01	4.55E-02	NaN	MAOA	
Signaling by NODAL	2E-01	4.35E-02	NaN	FOXO3	
Metabolism of porphyrins	2E-01	4.35E-02	NaN	SLCO2B1	
Vitamin-C Transport	2E-01	4.35E-02	NaN	LRRC8C	
Pyroptosis Signaling Pathway	-0E00	3.19E-02	NaN	FOXO3,KCNQ1OT1,NEK7	
Immunogenic Cell Death Signaling Pathway	-0E00	1.11E-02	NaN	ROCK1	
Macrophage Classical Activation Signaling Pathway	-0E00	2.65E-02	-1.000	JARID2,MERTK,PARP14,STAT3,TGFB2	
Multiple Sclerosis Signaling Pathway	-0E00	3.15E-02	2.646	BRAF,HLA-A,JARID2,PARP14,RNF213,TGFB2,TNKS	
Pathogen Induced Cytokine Storm Signaling Pathway	-0E00	1.35E-02	1.342	AP3B1,STAT3,TGFB2,VEGFC,VEGFD	
Chaperone Mediated Autophagy Signaling Pathway	-0E00	2.68E-02	-1.698	APP,ATP6V0A1,CREBBP,DDX3X,IGF1R,KAT2B,MAP2K4,MAPKAP1,NCOR1,PHLPP1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,PPP3CC,RICTOR	
NOD1/2 Signaling Pathway	-0E00	3.17E-02	1.633	ERBIN,MAP2K4,MAP4K4,TAB2,TGFB2,XIAP	
Microautophagy Signaling Pathway	-0E00	1.25E-02	NaN	PSME4,SEC24B	
NFKBIE Signaling Pathway	-0E00	1.11E-02	-0.447	ANKRD28,ANKRD44,DYSF,MAP3K3,PPP6R3	
LPS/IL-1 Mediated Inhibition of RXR Function	-0E00	3.89E-02	-0.447	ABCB1,ABCC4,CHST11,CPT1A,HMGCS2,MAOA,MAP2K4,MAP3K1,NCOA1,NDST1	
G alpha (i) signalling events	-0E00	1.16E-02	NaN	ADCY9,APP,GNG12	
Mitochondrial protein import	-0E00	1.56E-02	NaN	SLC25A12	
Potassium Channels	-0E00	9.71E-03	NaN	GNG12	
Formation of Fibrin Clot (Clotting Cascade)	-0E00	2.56E-02	NaN	VWF	
The citric acid (TCA) cycle and respiratory electron transport	-0E00	1.82E-02	NaN	SLC16A1	
Phase II - Conjugation of compounds	-0E00	1.49E-02	NaN	MTR	
Eukaryotic Translation Elongation	-0E00	1.05E-02	NaN	RPL31	
Telomere Maintenance	-0E00	4.11E-02	NaN	ANKRD28,ATRX,PPP6R3	
Sulfur amino acid metabolism	-0E00	4.17E-02	NaN	MTR	
Glycosaminoglycan metabolism	-0E00	3.75E-02	NaN	CSGALNACT1,EXT1,NDST1	
Electron transport, ATP synthesis, and heat production by uncoupling proteins	-0E00	7.81E-03	NaN	CYB5B	
MyD88-independent TLR4 cascade	-0E00	2.7E-02	NaN	TAB2	
Complement cascade	-0E00	7.41E-03	NaN	CD46	
Toll Like Receptor 3 (TLR3) Cascade	-0E00	3.12E-02	NaN	TAB2	
Regulation of Apoptosis	-0E00	3.77E-02	NaN	OPA1,PSME4	
Plasma lipoprotein assembly, remodeling, and clearance	-0E00	2.63E-02	NaN	CLTC,MBTPS2	
SRP-dependent cotranslational protein targeting to membrane	-0E00	8.7E-03	NaN	RPL31	
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	-0E00	9.9E-03	NaN	HLA-A,MICB	
Assembly of collagen fibrils and other multimeric structures	-0E00	1.64E-02	NaN	LAMA3	
Generic Transcription Pathway	-0E00	3.97E-02	4.123	CREBBP,HDAC4,HDAC7,HDAC8,KAT2B,MAML3,MED13,MED27,NCOR1,NOTCH4,NR1D1,NR1D2,NR2C2,NR3C2,RORA,TBL1X,ZNF445	
RNA Polymerase II Transcription	-0E00	4.03E-02	2.449	AFF4,CDC73,MLLT3,PAPOLA,RNGTT,THOC2	
Asparagine N-linked glycosylation	-0E00	3.23E-02	NaN	FUT8	
Gene Silencing by RNA	-0E00	4.21E-02	2.000	AGO1,AGO3,TNRC6B,TNRC6C	
MHC class II antigen presentation	-0E00	3.97E-02	2.236	AP1G1,CLTC,DNM3,DYNC1H1,SEC24B	
Arachidonic acid metabolism	-0E00	2.22E-02	NaN	PLA2G4A	
Integrin cell surface interactions	-0E00	3.53E-02	NaN	FN1,ITGA1,VWF	
Selenoamino acid metabolism	-0E00	9.35E-03	NaN	RPL31	
DNA Damage/Telomere Stress Induced Senescence	-0E00	3.57E-02	NaN	EP400,RB1	
Syndecan interactions	-0E00	3.7E-02	NaN	FN1	
HSP90 chaperone cycle for steroid hormone receptors in the presence of ligand	-0E00	3.64E-02	NaN	DYNC1H1,NR3C2	
Cellular response to heat stress	-0E00	3.09E-02	NaN	CREBBP,RPTOR,SIRT1	
Metabolism of polyamines	-0E00	1.69E-02	NaN	PSME4	
Class A/1 (Rhodopsin-like receptors)	-0E00	6.31E-03	NaN	APP,ECE1	
Class B/2 (Secretin family receptors)	-0E00	3.12E-02	NaN	CALCRL,FZD6,GNG12	
Energy dependent regulation of mTOR by LKB1-AMPK	-0E00	3.45E-02	NaN	RPTOR	
ATF4 activates genes in response to endoplasmic reticulum stress	-0E00	3.7E-02	NaN	ATF6	
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by IGFBPs	-0E00	3.23E-02	2.000	APP,CP,FN1,LAMB2	
ABC-family proteins mediated transport	-0E00	2.97E-02	NaN	ABCB1,ABCC4,PSME4	
Incretin synthesis, secretion, and inactivation	-0E00	4E-02	NaN	TCF7L2	
G alpha (s) signalling events	-0E00	4.14E-02	2.449	ADCY9,CALCRL,GNG12,GRK5,PDE7B,PDE8A	
Transport of inorganic cations/anions and amino acids/oligopeptides	-0E00	9.62E-03	NaN	SLC12A6	
SIRT1 negatively regulates rRNA expression	-0E00	3.45E-02	NaN	SIRT1	
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	-0E00	2.7E-02	NaN	CHD4	
Activation of NMDA receptors and postsynaptic events	-0E00	3.57E-02	NaN	DLG1,RASGRF2,RPS6KA3	
SUMOylation of DNA replication proteins	-0E00	2.22E-02	NaN	TOP2B	
Mitophagy	-0E00	3.33E-02	NaN	PRKN	
B-WICH complex positively regulates rRNA expression	-0E00	3.85E-02	NaN	BAZ1B,KAT2B	
DNA methylation	-0E00	3.85E-02	NaN	DNMT3A	
Hedgehog ligand biogenesis	-0E00	1.54E-02	NaN	PSME4	
Signaling by Retinoic Acid	-0E00	2.27E-02	NaN	CPT1A	
Hedgehog 'off' state	-0E00	2.65E-02	NaN	ADCY9,BTRC,PSME4	
RHO GTPases activate IQGAPs	-0E00	3.23E-02	NaN	CTNNA1	
TNFR2 non-canonical NF-kB pathway	-0E00	1.47E-02	NaN	PSME4	
NIK-->noncanonical NF-kB signaling	-0E00	3.33E-02	NaN	BTRC,PSME4	
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)	-0E00	2.68E-02	NaN	BABAM2,HERC2,SPIDR	
Nonhomologous End-Joining (NHEJ)	-0E00	4.08E-02	NaN	BABAM2,HERC2	
Cargo concentration in the ER	-0E00	2.94E-02	NaN	SEC24B	
Nucleotide Excision Repair	-0E00	1.03E-02	NaN	PIAS1	
Interleukin-10 signaling	-0E00	2.22E-02	NaN	STAT3	
Major pathway of rRNA processing in the nucleolus and cytosol	-0E00	5.38E-03	NaN	RPL31	
Neutrophil degranulation	-0E00	3.78E-02	4.243	ANO6,ATP11A,ATP6V0A1,ATP8A1,CDK13,DDX3X,DNAJC13,DNAJC5,DYNC1H1,HUWE1,PDXK,PLD1,PTPRB,PTPRJ,RAB10,ROCK1,SPTAN1,UBR4	
Regulation of TP53 Activity through Phosphorylation	-0E00	2.15E-02	NaN	HIPK1,HIPK2	
Keratinization	-0E00	4.67E-03	NaN	PKP4	
DNA Replication Pre-Initiation	-0E00	9.62E-03	NaN	ANAPC1	
Synthesis of DNA	-0E00	1.68E-02	NaN	ANAPC1,PSME4	
Glucose metabolism	-0E00	1.25E-02	NaN	SLC25A12	
mRNA Capping	-0E00	3.45E-02	NaN	RNGTT	
Processing of Capped Intron-Containing Pre-mRNA	-0E00	1.74E-02	2.236	HNRNPC,LUC7L3,PAPOLA,RBM5,THOC2	
Eukaryotic Translation Initiation	-0E00	2.46E-02	NaN	CP,EIF4G1,RPL31	
Eukaryotic Translation Termination	-0E00	1.06E-02	NaN	RPL31	
RNA Polymerase I Transcription	-0E00	4E-02	NaN	CHD4,KAT2B	
DNA Damage Bypass	-0E00	2.08E-02	NaN	TRIM25	
Processing of Capped Intronless Pre-mRNA	-0E00	3.45E-02	NaN	PAPOLA	
Fatty acyl-CoA biosynthesis	-0E00	3.7E-02	NaN	ACACA	
Mitochondrial Fatty Acid Beta-Oxidation	-0E00	4.17E-02	NaN	PCCA	
Nucleosome assembly	-0E00	4.08E-02	NaN	CENPC,RSF1	
Protein ubiquitination	-0E00	3.33E-02	NaN	USP9X	
TBC/RABGAPs	-0E00	2.27E-02	NaN	RABGAP1	
Interleukin-20 family signaling	-0E00	3.85E-02	NaN	STAT3	
RAB geranylgeranylation	-0E00	1.54E-02	NaN	RAB10	
Carboxyterminal post-translational modifications of tubulin	-0E00	2.22E-02	NaN	TTLL5	
Post-translational protein phosphorylation	-0E00	3.74E-02	2.000	APP,CP,FN1,LAMB2	
Peroxisomal protein import	-0E00	3.17E-02	NaN	IDE,USP9X	
Interferon alpha/beta signaling	-0E00	1.41E-02	NaN	HLA-A	
Iron uptake and transport	-0E00	3.45E-02	NaN	ATP6V0A1,CP	
Response of EIF2AK4 (GCN2) to amino acid deficiency	-0E00	9.71E-03	NaN	RPL31	
RAS processing	-0E00	4.17E-02	NaN	BCL2L1	
Sensory perception of taste	-0E00	2.13E-02	NaN	ITPR3	
Expression and translocation of olfactory receptors	-0E00	2.51E-03	NaN	EBF1	
Retinoid metabolism and transport	-0E00	2.27E-02	NaN	LRP8	
Coagulation System	-0E00	2.86E-02	NaN	VWF	
LXR/RXR Activation	-0E00	1.63E-02	NaN	ACACA,NCOR1	
CGAS-STING Signaling Pathway	-0E00	1.43E-02	NaN	ATP6V0A1,TGFB2	
FXR/RXR Activation	-0E00	2.67E-02	-0.447	AKT3,CREBBP,FOXO1,MAP2K4,TGFB2	
BBSome Signaling Pathway	-0E00	2.45E-02	2.714	ADGRF5,ASXL2,ATF6,BBS9,CALCRL,FZD6,IGF1R,INSR,MAP2K4,PCM1,PKD1,STAT3	
Activation of IRF by Cytosolic Pattern Recognition Receptors	-0E00	3.08E-02	NaN	CREBBP,MAP2K4	
Role of PKR in Interferon Induction and Antiviral Response	-0E00	2.94E-02	2.000	MAP2K4,PDGFD,STAT3,TAB2	
TREM1 Signaling	-0E00	3.9E-02	NaN	AKT3,PLCG1,STAT3	
Role of NFAT in Regulation of the Immune Response	-0E00	2.03E-02	3.638	AKT3,CSNK1G1,GNAQ,GNG12,HLA-A,ITPR1,ITPR2,ITPR3,MEF2C,NFAT5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,RCAN2,SOS2	
FcÎ³RIIB Signaling in B Lymphocytes	-0E00	1.69E-02	2.236	CACNA1A,ITPR1,ITPR2,ITPR3,MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3	
CCR5 Signaling in Macrophages	-0E00	2.4E-02	2.449	CACNA1A,GNAQ,GNG12,ITPR1,ITPR2,ITPR3,MAP2K4,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3	
Calcium-induced T Lymphocyte Apoptosis	-0E00	2.39E-02	3.317	HLA-A,ITPR1,ITPR2,ITPR3,PLCG1,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3	
Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells	-0E00	2.35E-03	NaN	HLA-A	
Airway Pathology in Chronic Obstructive Pulmonary Disease	-0E00	8.47E-03	NaN	TGFB2	
4-1BB Signaling in T Lymphocytes	-0E00	2.94E-02	NaN	MAP2K4	
CTLA4 Signaling in Cytotoxic T Lymphocytes	-0E00	2.96E-02	-0.943	AKT3,AP1G1,BCL2L1,CBLB,CLTC,HLA-A,MAP2K4,NFAT5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PLD1,PPM1L,PPP2R5E,TGFB2,YES1	
Airway Inflammation in Asthma	-0E00	3.03E-02	NaN	TGFB2	
T Helper Cell Differentiation	-0E00	6.37E-03	NaN	HLA-A,STAT3,TGFBR2	
CD28 Signaling in T Helper Cells	-0E00	2.9E-02	3.742	AKT3,HLA-A,ITPR1,ITPR2,ITPR3,MAP2K4,MAP3K1,NFAT5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPP3CA,PPP3CC	
IL-15 Signaling	-0E00	1.52E-02	2.828	AKT3,BCL2L1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RPTOR,STAT3	
Dendritic Cell Maturation	-0E00	2.01E-02	3.317	AKT3,CREB3L2,CREBBP,HLA-A,MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1	
ICOS-ICOSL Signaling in T Helper Cells	-0E00	2.96E-02	2.887	AKT3,GAB2,HLA-A,ITPR1,ITPR2,ITPR3,NFAT5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPP3CA,PPP3CC,PTEN	
Maturity Onset Diabetes of Young (MODY) Signaling	-0E00	3.8E-02	NaN	CACNA1A,CREBBP,INSR	
Type I Diabetes Mellitus Signaling	-0E00	5.89E-03	NaN	HLA-A,MAP2K4,PIAS1	
Allograft Rejection Signaling	-0E00	2.05E-03	NaN	HLA-A	
Autoimmune Thyroid Disease Signaling	-0E00	2.18E-03	NaN	HLA-A	
Graft-versus-Host Disease Signaling	-0E00	2.24E-03	NaN	HLA-A	
p70S6K Signaling	-0E00	2.94E-02	3.500	AKT3,GNAQ,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PLD1,PPM1L,PPP2R5E,PRKCE,PRKCH,PRKCI,PRKD3,SOS2	
G Protein Signaling Mediated by Tubby	-0E00	1.5E-02	2.646	GNAQ,GNG12,INSR,MERTK,PLCB1,PLCB4,PLCG1	
Communication between Innate and Adaptive Immune Cells	-0E00	1.07E-03	NaN	HLA-A	
Systemic Lupus Erythematosus Signaling	-0E00	1.13E-02	NaN	AKT3,CBL,HLA-A,HNRNPC,NFAT5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRPF39,SOS2	
CDC42 Signaling	-0E00	2.6E-02	-0.378	APC,CDC42BPA,EXOC2,EXOC4,EXOC6,EXOC6B,HLA-A,ITGA1,MAP2K4,MPRIP,PARD3,PPP1R12A,Ppp1r12b,PRKCI,WIPF1	
FAK Signaling	-0E00	3.75E-02	5.604	ACVR1,ADGRF5,AKT3,APC,ARHGAP35,ASAP1,BMPR2,CALCRL,DOCK1,EFNB2,ELF2,ETS1,FLT1,FLT4,FZD6,GHR,GIT2,IGF1R,IL17RD,ITGA1,LEF1,MAP2K4,MAP2K5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PTEN,PTK2,RB1CC1,SOS2,TCF4,TCF7L1,TCF7L2,TGFB2,TGFBR2,TGFBR3,WIPF1	
Retinoic acid Mediated Apoptosis Signaling	-0E00	3.33E-02	NaN	PARP14,TNKS	
Phospholipase C Signaling	-0E00	3.21E-02	4.158	ADCY9,AHNAK,ARHGEF10,ARHGEF11,ARHGEF12,ARHGEF3,ARHGEF9,CREB3L2,CREBBP,GNAQ,GNG12,HDAC4,HDAC7,HDAC8,ITGA1,ITPR1,ITPR2,ITPR3,MEF2C,MPRIP,NFAT5,PLA2G4A,PLCB1,PLCB4,PLCG1,PLD1,PPP1R12A,Ppp1r12b,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,RPS6KA3,SOS2	
Altered T Cell and B Cell Signaling in Rheumatoid Arthritis	-0E00	1.07E-03	NaN	HLA-A	
Atherosclerosis Signaling	-0E00	2.26E-02	NaN	GLG1,PDGFD,PLA2G4A	
B Cell Development	-0E00	2.05E-03	NaN	HLA-A	
Neuroprotective Role of THOP1 in Alzheimer's Disease	-0E00	3.28E-02	NaN	APP,ECE1,HLA-A,IDE	
Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes	-0E00	1.95E-02	1.667	MAP2K4,MAP3K1,NFAT5,PLCG1,PPP3CA,PPP3CC,SOS2,TGFB2,TGFBR2	
Granzyme A Signaling	-0E00	1.35E-02	NaN	FN1	
TWEAK Signaling	-0E00	2.7E-02	NaN	XIAP	
NUR77 Signaling in T Lymphocytes	-0E00	2.53E-02	2.309	HDAC7,HLA-A,MAP2K5,MAP3K2,MAP3K3,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,RPS6KA3,SIN3A	
PKCÎ¸ Signaling in T Lymphocytes	-0E00	3.41E-02	3.742	CACNA1A,HLA-A,ITPR1,ITPR2,ITPR3,MAP2K4,MAP3K1,MAP3K2,MAP3K3,NFAT5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,POU2F1,PPP3CA,PPP3CC,SOS2	
Role of MAPK Signaling in the Pathogenesis of Influenza	-0E00	3.57E-02	NaN	AKT3,MAP2K4,PLA2G4A	
Antiproliferative Role of TOB in T Cell Signaling	-0E00	7.04E-03	NaN	RB1,TGFB2,TGFBR2	
OX40 Signaling Pathway	-0E00	6.28E-03	NaN	BCL2L1,HLA-A,MAP2K4	
PI3K Signaling in B Lymphocytes	-0E00	3.06E-02	3.153	AKT3,ATF6,ATF7,CBL,FOXO3,ITPR1,ITPR2,ITPR3,NFAT5,PIK3CA,PIK3R1,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,PRKCI,PTEN	
MIF-mediated Glucocorticoid Regulation	-0E00	2.78E-02	NaN	PLA2G4A	
IL-17A Signaling in Fibroblasts	-0E00	3.45E-02	NaN	FN1,MAP2K4,STAT3	
IL-17A Signaling in Gastric Cells	-0E00	3.85E-02	NaN	MAP2K4	
Role of JAK1, JAK2 and TYK2 in Interferon Signaling	-0E00	3.85E-02	NaN	STAT3	
Estrogen-mediated S-phase Entry	-0E00	3.85E-02	NaN	RB1	
Nicotine Degradation III	-0E00	3.33E-02	NaN	CSGALNACT1,LARGE1	
Dopamine Degradation	-0E00	3.12E-02	NaN	MAOA	
Melatonin Degradation I	-0E00	3.12E-02	NaN	CSGALNACT1,LARGE1	
NAD Salvage Pathway II	-0E00	3.7E-02	NaN	NT5C2	
Tryptophan Degradation X (Mammalian, via Tryptamine)	-0E00	3.7E-02	NaN	MAOA	
tRNA Charging	-0E00	2.56E-02	NaN	FARS2	
Dermatan Sulfate Biosynthesis (Late Stages)	-0E00	4E-02	NaN	CHST11,NDST1	
Nicotine Degradation II	-0E00	2.94E-02	NaN	CSGALNACT1,LARGE1	
Serotonin Degradation	-0E00	4.11E-02	NaN	CSGALNACT1,LARGE1,MAOA	
Retinol Biosynthesis	-0E00	2.08E-02	NaN	LIPE	
Triacylglycerol Biosynthesis	-0E00	1.79E-02	NaN	SIRT1	
Stearate Biosynthesis I (Animals)	-0E00	1.41E-02	NaN	SIRT1	
Noradrenaline and Adrenaline Degradation	-0E00	2.7E-02	NaN	MAOA	
Oxidative Ethanol Degradation III	-0E00	1.79E-02	NaN	DIP2A	
Ethanol Degradation IV	-0E00	4E-02	NaN	DIP2A	
Ethanol Degradation II	-0E00	2.86E-02	NaN	DIP2A	
Methionine Degradation I (to Homocysteine)	-0E00	4.17E-02	NaN	EHMT1	
Superpathway of Cholesterol Biosynthesis	-0E00	3.45E-02	NaN	HMGCS2	
GÎ±i Signaling	-0E00	3.57E-02	NaN	ADCY9,GNAQ,GNG12,SOS2,STAT3	
Inhibition of Matrix Metalloproteases	-0E00	2.56E-02	NaN	RECK	
Cysteine Biosynthesis III (mammalia)	-0E00	3.85E-02	NaN	EHMT1	
Agranulocyte Adhesion and Diapedesis	-0E00	3.33E-02	NaN	FN1,GLG1,MYH10,MYH9,MYO10,MYO18A,Podxl	
Granulocyte Adhesion and Diapedesis	-0E00	5.29E-03	NaN	GLG1	
TEC Kinase Signaling	-0E00	2.94E-02	3.742	GNAQ,GNG12,GTF2I,ITGA1,MAP2K4,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCE,PRKCH,PRKCI,PRKD3,PTK2,STAT3,YES1	
Oxidative Phosphorylation	-0E00	8.93E-03	NaN	CYB5B	
SAPK/JNK Signaling	-0E00	2.99E-02	3.606	GAB1,GNG12,MAP2K4,MAP3K1,MAP3K2,MAP3K20,MAP3K3,MAP4K3,MAP4K4,MAPK8IP3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SOS2	
Interferon Signaling	-0E00	2.78E-02	NaN	PIAS1	
IL-4 Signaling	-0E00	2.77E-02	4.000	AKT3,BCL2L1,CREB3L2,CREBBP,GAB1,MAOA,MAPKAP1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RICTOR,RPTOR,SOS2,STAT3,TGFB2	
Antigen Presentation Pathway	-0E00	2.56E-02	NaN	HLA-A	
B Cell Receptor Signaling	-0E00	3.94E-02	3.128	AKT3,BCL2L1,CREB3L2,CREBBP,EBF1,ETS1,FOXO1,GAB1,GAB2,INPP5F,MAP2K4,MAP3K1,MAP3K2,MAP3K3,MEF2C,NFAT5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,PPP3CC,PTEN,PTK2,SOS2	
Sonic Hedgehog Signaling	-0E00	3.23E-02	NaN	DYRK1A	
Glutamate Receptor Signaling	-0E00	1.52E-02	NaN	GNG12	
NF-ÎºB Signaling	-0E00	3.85E-02	4.264	AKT3,BMPR2,BRAF,BTRC,CREBBP,FLT1,FLT4,GHR,IGF1R,INSR,IRAK3,MAP3K1,MAP3K3,MAP4K4,PELI1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,TAB2,TGFBR2,TGFBR3	
T Cell Receptor Signaling	-0E00	3.25E-02	3.578	AKT3,CBL,FOXO3,HLA-A,LEF1,MAP2K4,MAP3K1,NFAT5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPP3CA,PPP3CC,RPTOR,SOS2,TCF4,TCF7L1,TCF7L2	
Gustation Pathway	-0E00	3.96E-02	2.828	ADCY9,CACNA1A,ITPR1,ITPR2,ITPR3,LIPE,LRRC8C,STIM1	
Phagosome Maturation	-0E00	3.66E-02	NaN	ATP6V0A1,DYNC1H1,EEA1,HLA-A,PIKFYVE,VTI1A	
Sirtuin Signaling Pathway	-0E00	3.44E-02	2.121	APP,CPT1A,EPAS1,FOXO1,FOXO3,GABPB2,HMGCS2,RPTOR,SIRT1,STAT3	
Th17 Activation Pathway	-0E00	8.26E-03	2.000	IRAK3,NFAT5,RORA,STAT3	
SPINK1 Pancreatic Cancer Pathway	-0E00	3.33E-02	NaN	CPD,TGFBR2	
NER (Nucleotide Excision Repair, Enhanced Pathway)	-0E00	1.1E-02	NaN	TOP2B	
Apelin Liver Signaling Pathway	-0E00	3.7E-02	NaN	MAP2K4	
Apelin Adipocyte Signaling Pathway	-0E00	2.2E-02	NaN	ADCY9,LIPE	
BAG2 Signaling Pathway	-0E00	2.35E-02	NaN	PRKN,PSME4	
FAT10 Signaling Pathway	-0E00	1.75E-02	NaN	PSME4	
T Cell Exhaustion Signaling Pathway	-0E00	3E-02	0.535	ACVR1,AKT3,BMPR2,FOXO1,HLA-A,MAP2K4,NFAT5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPM1L,PPP2R5E,STAT3,TGFBR2,TGFBR3	
Systemic Lupus Erythematosus in T Cell Signaling Pathway	-0E00	3.73E-02	2.558	AKT3,CBL,CREB3L2,CREBBP,HLA-A,ITPR1,MAP2K4,MAP2K5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPM1L,PPP2R5E,PPP3CA,PPP3CC,PTK2,ROCK1,RPTOR,SOS2,STAT3,STIM1,YES1	
Systemic Lupus Erythematosus in B Cell Signaling Pathway	-0E00	3.18E-02	3.545	AKT3,BCL2L1,CBL,FOXO1,FOXO3,GAB1,INPP5F,MAP4K4,NFAT5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,PPP3CC,PRKCE,PRKCH,PRKCI,PRKD3,SOS2,STAT3,TGFB2,YES1	
Complement System	-0E00	2.7E-02	NaN	CD46	
